<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vaccines (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Vaccines (Basel)</journal-id><journal-id journal-id-type="publisher-id">vaccines</journal-id><journal-title-group><journal-title>Vaccines</journal-title></journal-title-group><issn pub-type="epub">2076-393X</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11680286</article-id><article-id pub-id-type="doi">10.3390/vaccines12121411</article-id><article-id pub-id-type="publisher-id">vaccines-12-01411</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Vaccine Hesitancy and Associated Factors Amongst Health Professionals: A Scoping Review of the Published Literature</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0544-851X</contrib-id><name><surname>Christodoulakis</surname><given-names>Antonios</given-names></name><xref rid="af1-vaccines-12-01411" ref-type="aff">1</xref><xref rid="af2-vaccines-12-01411" ref-type="aff">2</xref><xref rid="fn1-vaccines-12-01411" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5903-3550</contrib-id><name><surname>Bouloukaki</surname><given-names>Izolde</given-names></name><xref rid="af1-vaccines-12-01411" ref-type="aff">1</xref><xref rid="c1-vaccines-12-01411" ref-type="corresp">*</xref><xref rid="fn1-vaccines-12-01411" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9104-9525</contrib-id><name><surname>Aravantinou-Karlatou</surname><given-names>Antonia</given-names></name><xref rid="af1-vaccines-12-01411" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5376-9580</contrib-id><name><surname>Zografakis-Sfakianakis</surname><given-names>Michail</given-names></name><xref rid="af2-vaccines-12-01411" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7922-7491</contrib-id><name><surname>Tsiligianni</surname><given-names>Ioanna</given-names></name><xref rid="af1-vaccines-12-01411" ref-type="aff">1</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Plans-Rubi&#x000f3;</surname><given-names>Pedro</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-vaccines-12-01411"><label>1</label>Department of Social Medicine, School of Medicine, University of Crete, 71500 Heraklion, Greece; <email>christodoulakisa@uoc.gr</email> (A.C.); <email>medp2012149@med.uoc.gr</email> (A.A.-K.); <email>i.tsiligianni@uoc.gr</email> (I.T.)</aff><aff id="af2-vaccines-12-01411"><label>2</label>Department of Nursing, School of Health Sciences, Hellenic Mediterranean University, 71410 Heraklion, Greece; <email>mzografakis@hmu.gr</email></aff><author-notes><corresp id="c1-vaccines-12-01411"><label>*</label>Correspondence: <email>izolthi@gmail.com</email>; Tel.: +30-28-1-039-4607</corresp><fn id="fn1-vaccines-12-01411"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>13</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><volume>12</volume><issue>12</issue><elocation-id>1411</elocation-id><history><date date-type="received"><day>07</day><month>10</month><year>2024</year></date><date date-type="rev-recd"><day>05</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>11</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><bold>Background/Objectives:</bold> Healthcare professionals (HCPs) hold significant influence over public attitudes toward vaccinations. Studies suggest that HCPs are hesitant towards the coronavirus disease 2019 (COVID-19) vaccines. This hesitancy could lead to lower vaccination rates in the community. Therefore, this scoping review aimed to assess the extent of hesitancy towards COVID-19 booster doses among HCPs and identify the associated factors. <bold>Methods:</bold> A comprehensive search was conducted in the PubMed and Scopus databases from April to August 2024, using keywords related to COVID-19, vaccine hesitancy, HCPs, and booster vaccination. Studies that had been peer-reviewed, published in English after 2022, and focused on the hesitancy of the COVID-19 booster dose hesitancy among HCPs were included. Out of the 6703 studies screened, 24 studies were included. <bold>Results:</bold> Most of the HCPs have received their initial series of COVID-19 vaccinations. However, there is a lower rate of uptake for booster doses, with hesitancy rates ranging from 12% to 66.5%. Hesitancy rates varied significantly across continents, with Asia, Africa, and Europe ranging from 19.7% to 66.5%, 27% to 46.1%, 14% to 60.2%, respectively. Hesitancy was reported to be influenced by various factors, including concerns about vaccine safety, necessity, and effectiveness of these vaccines. In addition, the hesitancy regarding booster doses was also found to be influenced by factors like age, gender, profession, and previous COVID-19. Physicians, nurses, and pharmacists exhibited vaccine hesitancy rates ranging from 12.8% to 43.7%, 26% to 37%, and 26% to 34.6%, respectively. <bold>Conclusions:</bold> Our review underscores the hesitancy among HCPs towards receiving booster doses across countries around the world and explores the underlying factors. These findings provide valuable insights for the design of future pandemic vaccination programs.</p></abstract><kwd-group><kwd>vaccination hesitancy</kwd><kwd>booster dose</kwd><kwd>healthcare professionals</kwd><kwd>COVID-19</kwd><kwd>reasons</kwd><kwd>factors</kwd><kwd>review</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-vaccines-12-01411"><title>1. Introduction</title><p>The outbreak of the coronavirus disease 2019 (COVID-19) has caused a worldwide emergency situation, affecting various aspects of human life [<xref rid="B1-vaccines-12-01411" ref-type="bibr">1</xref>]. The unprecedented onset of the COVID-19 pandemic has also imposed a significant burden on healthcare systems worldwide [<xref rid="B1-vaccines-12-01411" ref-type="bibr">1</xref>]. Measures like social distancing, wearing face masks in public, lockdowns, and quarantines have helped to initially control the transmission of the virus [<xref rid="B2-vaccines-12-01411" ref-type="bibr">2</xref>,<xref rid="B3-vaccines-12-01411" ref-type="bibr">3</xref>]. However, to return to normal life, long-term solutions such as universal vaccination were needed [<xref rid="B2-vaccines-12-01411" ref-type="bibr">2</xref>,<xref rid="B4-vaccines-12-01411" ref-type="bibr">4</xref>,<xref rid="B5-vaccines-12-01411" ref-type="bibr">5</xref>]. In this context, the development of COVID-19 vaccines has been suggested to combat the pandemic, by reducing the severity of illness and lowering the spread of the virus [<xref rid="B6-vaccines-12-01411" ref-type="bibr">6</xref>,<xref rid="B7-vaccines-12-01411" ref-type="bibr">7</xref>]. Nevertheless, even though the pandemic has been effectively controlled, the virus is still spreading, due to the emergence of new strains of COVID-19 and the declining effectiveness of primary doses of the COVID-19 vaccines [<xref rid="B8-vaccines-12-01411" ref-type="bibr">8</xref>,<xref rid="B9-vaccines-12-01411" ref-type="bibr">9</xref>,<xref rid="B10-vaccines-12-01411" ref-type="bibr">10</xref>]. This has prompted the World Health Organization (WHO) to consistently update its recommendations for COVID-19 vaccination. These updates emphasize the importance of vaccinating both the general public and healthcare professionals (HCPs) [<xref rid="B11-vaccines-12-01411" ref-type="bibr">11</xref>].</p><p>HCPs are frequently considered a target population for vaccination initiatives, as they possess characteristics typically associated with vaccine acceptance. These include a high level of education, clinical experience, and affiliation with professional organizations that advocate for vaccination [<xref rid="B12-vaccines-12-01411" ref-type="bibr">12</xref>]. Moreover, HCPs were prioritized for the COVID-19 vaccine due to their occupational exposure and frequent interaction with infected individuals [<xref rid="B13-vaccines-12-01411" ref-type="bibr">13</xref>]. However, their willingness to get vaccinated varied and often fell short of expectations [<xref rid="B14-vaccines-12-01411" ref-type="bibr">14</xref>]. Encouraging positive attitudes towards vaccination among HCPs was proposed not only for ensuring their personal safety, as well as the safety of their families and patients, but also to promote its acceptance among others [<xref rid="B15-vaccines-12-01411" ref-type="bibr">15</xref>]. The reason behind this is that HCPs act as facilitators and communicators for vaccines to patients and the general public [<xref rid="B16-vaccines-12-01411" ref-type="bibr">16</xref>,<xref rid="B17-vaccines-12-01411" ref-type="bibr">17</xref>,<xref rid="B18-vaccines-12-01411" ref-type="bibr">18</xref>]. More specifically, during both the initial and subsequent COVID-19 vaccination campaigns, HCPs had the role of addressing concerns and misunderstandings about COVID-19 vaccination, and supporting the benefits of getting vaccinated [<xref rid="B19-vaccines-12-01411" ref-type="bibr">19</xref>,<xref rid="B20-vaccines-12-01411" ref-type="bibr">20</xref>]. Several studies have reported resistance to receiving COVID-19 booster doses (BDs) which could potentially negatively impact trust in vaccines among the general population [<xref rid="B17-vaccines-12-01411" ref-type="bibr">17</xref>,<xref rid="B21-vaccines-12-01411" ref-type="bibr">21</xref>,<xref rid="B22-vaccines-12-01411" ref-type="bibr">22</xref>]. If HCPs exhibit hesitancy or resistance towards receiving the vaccine, it could reflect a similar attitude among patients, influencing public opinion [<xref rid="B23-vaccines-12-01411" ref-type="bibr">23</xref>].</p><p>The European Centre for Disease Prevention and Control defines vaccine hesitancy as the &#x0201c;delay in acceptance or refusal of vaccines despite availability of vaccination services&#x0201d; [<xref rid="B24-vaccines-12-01411" ref-type="bibr">24</xref>]. The distribution of initial vaccine hesitancy among HCPs appears to vary, with certain characteristics such as age, sex, race/ethnicity, political affiliation, professional role, and healthcare facility type identified as predictors of vaccine uptake [<xref rid="B25-vaccines-12-01411" ref-type="bibr">25</xref>,<xref rid="B26-vaccines-12-01411" ref-type="bibr">26</xref>,<xref rid="B27-vaccines-12-01411" ref-type="bibr">27</xref>,<xref rid="B28-vaccines-12-01411" ref-type="bibr">28</xref>,<xref rid="B29-vaccines-12-01411" ref-type="bibr">29</xref>,<xref rid="B30-vaccines-12-01411" ref-type="bibr">30</xref>]. Furthermore, the way HCPs perceive their vulnerability to and the seriousness of COVID-19, as well as their past experience testing positive for the virus, greatly impacted their decision to get vaccinated [<xref rid="B26-vaccines-12-01411" ref-type="bibr">26</xref>,<xref rid="B29-vaccines-12-01411" ref-type="bibr">29</xref>]. Importantly, HCPs&#x02019; initial hesitancy towards vaccinations appears to remain when it comes to receiving BDs of the COVID-19 vaccine, although studies indicate varying levels of acceptance and hesitancy towards BDs [<xref rid="B31-vaccines-12-01411" ref-type="bibr">31</xref>,<xref rid="B32-vaccines-12-01411" ref-type="bibr">32</xref>,<xref rid="B33-vaccines-12-01411" ref-type="bibr">33</xref>,<xref rid="B34-vaccines-12-01411" ref-type="bibr">34</xref>]. Based on the initial findings, HCPs viewed BDs as less important and expressed a lack of confidence in them [<xref rid="B35-vaccines-12-01411" ref-type="bibr">35</xref>]. Recent data on vaccine uptake indicates that the significance of perceiving COVID-19 vaccination as necessary seems to diminish, with a lower number of HCPs receiving BDs compared to those who received the initial two doses [<xref rid="B36-vaccines-12-01411" ref-type="bibr">36</xref>]. Due to the dynamic nature of the virus, the potential for viral mutations, and the likelihood of declining immunity, understanding HCPs&#x02019; hesitancy to receive regular COVID-19 vaccines has significant value for guiding vaccination campaigns.</p><p>While concerns regarding vaccine hesitancy among HCPs remain, potentially contributing to disparities in BD uptake, few studies have thoroughly examined the differences in characteristics between HCPs who have received COVID-19 BDs and those who have not. Therefore, the aim of this scoping review was to assess the level of COVID-19 vaccine hesitancy among HCPs and identify the underlying factors that contribute to this hesitancy.</p></sec><sec id="sec2-vaccines-12-01411"><title>2. Materials and Methods</title><p>This scoping review followed the JBI guidelines for conducting scoping reviews [<xref rid="B37-vaccines-12-01411" ref-type="bibr">37</xref>], and the findings were reported using the PRISMA-ScR checklist <xref rid="app1-vaccines-12-01411" ref-type="app">Supplementary Materials Table S1</xref> [<xref rid="B38-vaccines-12-01411" ref-type="bibr">38</xref>]. The research protocol was retrospectively registered (protocol number: INPLASY2024100036) on the International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY) at <uri xlink:href="https://doi.org/10.37766/inplasy2024.10.0036">https://doi.org/10.37766/inplasy2024.10.0036</uri> in October 2024, accessed on 9 October 2024.</p><sec id="sec2dot1-vaccines-12-01411"><title>2.1. Eligibility Criteria</title><p>This scoping review focused on two key questions: What is the prevalence of COVID-19 hesitancy among HCPs worldwide, and what are the factors that contribute to this hesitancy? Our scope was global, encompassing studies from all geographical locations without any specific focus on a particular population. This inclusivity ensured that our review captured a diverse range of perspectives and settings. Therefore, in order to be included in this review, studies had to meet the following criteria: (1) being peer-reviewed articles published in English, (2) focusing on HCPs, (3) investigating COVID-19 vaccine hesitancy, acceptance on booster vaccination, and (4) being published from January 2022 onwards. The exclusion criteria included articles that were not peer-reviewed, editorials, opinion pieces, and studies that focused on non-healthcare professional populations. The study selection process included two stages: screening titles and abstracts, and then conducting a full-text review. Two reviewers independently performed the screening process. Differences among reviewers were addressed through discussion and by involving a third reviewer to reach consensus. To maintain transparency and reproducibility, we employed a PRISMA flow diagram to document the selection process.</p></sec><sec id="sec2dot2-vaccines-12-01411"><title>2.2. Information Sources and Search</title><p>A comprehensive approach was taken to find relevant literature through a search strategy. To ensure comprehensive coverage of medical and scientific journals, a literature search was performed in two major literature databases, PubMed and Scopus, from April to August 2024. The search terms used were a mix of keywords and Medical Subject Headings (MeSHs) related to COVID-19, vaccine hesitancy, healthcare professionals, and booster vaccinations. Therefore, we employed in both databases the following keyword combinations and Boolean operators (AND, OR): &#x0201c;COVID-19&#x0201d;, &#x0201c;vaccine hesitancy&#x0201d;, &#x0201c;healthcare professionals&#x0201d;, and &#x0201c;booster vaccination&#x0201d;. The search method was based on prior systematic reviews which analyzed vaccine hesitancy towards the COVID-19 vaccine in general populations and HCPs [<xref rid="B17-vaccines-12-01411" ref-type="bibr">17</xref>,<xref rid="B31-vaccines-12-01411" ref-type="bibr">31</xref>].</p></sec><sec id="sec2dot3-vaccines-12-01411"><title>2.3. Data Extraction and Analysis</title><p>In this scoping review, we analyzed the data regarding regular COVID-19 vaccination hesitancy in HCPs. This entailed the extraction of information about study design, prevalence of COVID-19 vaccination hesitancy, knowledge, attitudes and factors associated with it in HCPs, of full texts and related results of the included studies by two reviewers using a standardized form for data extraction. After removing duplicates, two independent reviewers evaluated each extraction form, and discussed any discrepancies in a thorough appraisal process. In the extracted data, details about the studies, including the author, year, and country, were added. It also provided information about the participants, such as their profession and sample size. The data encompassed the study design, key findings related to vaccine hesitancy and acceptance, any barriers and challenges that were identified, as well as the coping strategies that were utilized. Two independent reviewers performed the data extraction to guarantee accuracy and consistency. All disagreements during the review&#x02019;s inclusion phase were resolved through discussion to reach a consensus. In instances where reviewer consensus was not achieved, a third, independent reviewer was employed for arbitration. We employed thematic analysis in our research to categorize factors associated with vaccine hesitancy [<xref rid="B39-vaccines-12-01411" ref-type="bibr">39</xref>]. Thematic analysis included identifying, analyzing, and reporting patterns in the data.</p></sec></sec><sec sec-type="results" id="sec3-vaccines-12-01411"><title>3. Results</title><sec id="sec3dot1-vaccines-12-01411"><title>3.1. Screening and Procedure</title><p>A total of 6703 studies were yielded during the first database search for this scoping review. Following the first screening and removal of duplicates, a total of 4303 articles underwent screening based on their titles. Afterwards, 880 titles met the inclusion criteria and were chosen for further assessment, primarily based on their abstracts. Subsequently, a second/further evaluation was conducted on 44 abstracts that satisfied the inclusion criteria, and their full texts were obtained to be further screened. However, 20 studies were excluded in accordance with the criteria for inclusion/exclusion as described in the methodology. Therefore, 24 full-text studies were finally included in this scoping review. The PRISMA flow diagram in <xref rid="vaccines-12-01411-f001" ref-type="fig">Figure 1</xref> shows the process for the literature search.</p></sec><sec id="sec3dot2-vaccines-12-01411"><title>3.2. Overview of Characteristics of the Included Studies</title><p>The characteristics of the 24 included studies [<xref rid="B22-vaccines-12-01411" ref-type="bibr">22</xref>,<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B41-vaccines-12-01411" ref-type="bibr">41</xref>,<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>,<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>,<xref rid="B55-vaccines-12-01411" ref-type="bibr">55</xref>,<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>,<xref rid="B58-vaccines-12-01411" ref-type="bibr">58</xref>,<xref rid="B59-vaccines-12-01411" ref-type="bibr">59</xref>,<xref rid="B60-vaccines-12-01411" ref-type="bibr">60</xref>,<xref rid="B61-vaccines-12-01411" ref-type="bibr">61</xref>,<xref rid="B62-vaccines-12-01411" ref-type="bibr">62</xref>] have been outlined in <xref rid="vaccines-12-01411-t001" ref-type="table">Table 1</xref>. All studies were categorized as cross-sectional [<xref rid="B22-vaccines-12-01411" ref-type="bibr">22</xref>,<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B41-vaccines-12-01411" ref-type="bibr">41</xref>,<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>,<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>,<xref rid="B55-vaccines-12-01411" ref-type="bibr">55</xref>,<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>,<xref rid="B58-vaccines-12-01411" ref-type="bibr">58</xref>,<xref rid="B59-vaccines-12-01411" ref-type="bibr">59</xref>,<xref rid="B60-vaccines-12-01411" ref-type="bibr">60</xref>,<xref rid="B61-vaccines-12-01411" ref-type="bibr">61</xref>,<xref rid="B62-vaccines-12-01411" ref-type="bibr">62</xref>], with one of them utilizing a mixed methods approach (combining qualitative and quantitative data) [<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>]. The included studies were conducted on five out of seven continents, with four studies from the United States of America (USA) [<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B55-vaccines-12-01411" ref-type="bibr">55</xref>,<xref rid="B61-vaccines-12-01411" ref-type="bibr">61</xref>,<xref rid="B62-vaccines-12-01411" ref-type="bibr">62</xref>], two studies from Africa (South Africa and Kongo) [<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B58-vaccines-12-01411" ref-type="bibr">58</xref>], ten from Asia (China, India, Jordan, Nepal, Israel, Kingdom of Bahrain and Egypt, Palestine, Pakistan, Malaysia) [<xref rid="B22-vaccines-12-01411" ref-type="bibr">22</xref>,<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>,<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>,<xref rid="B59-vaccines-12-01411" ref-type="bibr">59</xref>] and eight from Europe (England, Italy, Greece, Belgium, Slovenia) [<xref rid="B41-vaccines-12-01411" ref-type="bibr">41</xref>,<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>,<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>,<xref rid="B60-vaccines-12-01411" ref-type="bibr">60</xref>]. Studies from Asia accounted for 42% of the studies analyzed (10 studies) [<xref rid="B22-vaccines-12-01411" ref-type="bibr">22</xref>,<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>,<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>,<xref rid="B59-vaccines-12-01411" ref-type="bibr">59</xref>]. The studies were published from January 2022 to August 2024.</p></sec><sec id="sec3dot3-vaccines-12-01411"><title>3.3. Measures</title><p>Sociodemographic characteristics were recorded in all of the studies included [<xref rid="B22-vaccines-12-01411" ref-type="bibr">22</xref>,<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B41-vaccines-12-01411" ref-type="bibr">41</xref>,<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>,<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>,<xref rid="B55-vaccines-12-01411" ref-type="bibr">55</xref>,<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>,<xref rid="B58-vaccines-12-01411" ref-type="bibr">58</xref>,<xref rid="B59-vaccines-12-01411" ref-type="bibr">59</xref>,<xref rid="B60-vaccines-12-01411" ref-type="bibr">60</xref>,<xref rid="B61-vaccines-12-01411" ref-type="bibr">61</xref>,<xref rid="B62-vaccines-12-01411" ref-type="bibr">62</xref>]. The majority of the studies assessed the participants&#x02019; vaccination history, including the number of BDs received and the type of vaccine administered [<xref rid="B22-vaccines-12-01411" ref-type="bibr">22</xref>,<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>,<xref rid="B58-vaccines-12-01411" ref-type="bibr">58</xref>,<xref rid="B59-vaccines-12-01411" ref-type="bibr">59</xref>,<xref rid="B60-vaccines-12-01411" ref-type="bibr">60</xref>,<xref rid="B61-vaccines-12-01411" ref-type="bibr">61</xref>,<xref rid="B62-vaccines-12-01411" ref-type="bibr">62</xref>]. In addition, the studies included specific questions about willingness to take the COVID-19 vaccine BDs [<xref rid="B22-vaccines-12-01411" ref-type="bibr">22</xref>,<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>,<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>,<xref rid="B58-vaccines-12-01411" ref-type="bibr">58</xref>,<xref rid="B59-vaccines-12-01411" ref-type="bibr">59</xref>], vaccination trust [<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>], knowledge [<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>] and perceived benefit [<xref rid="B22-vaccines-12-01411" ref-type="bibr">22</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>,<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>,<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>]. Questions related to attitudes about BDs [<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>,<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>,<xref rid="B61-vaccines-12-01411" ref-type="bibr">61</xref>], COVID-19 diagnosis and risk [<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B60-vaccines-12-01411" ref-type="bibr">60</xref>], barriers for BDs [<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>], health status factors [<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B58-vaccines-12-01411" ref-type="bibr">58</xref>,<xref rid="B60-vaccines-12-01411" ref-type="bibr">60</xref>] and psychological drivers for BDs [<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>] were also included and have been outlined in <xref rid="vaccines-12-01411-t001" ref-type="table">Table 1</xref>. Furthermore, specific assessment tools were used to evaluate vaccination hesitancy among HCPs, focusing on HCPs&#x02019; knowledge, attitudes, and other factors associated with it. In particular, the specific tools used were the Belief Medicine Questionnaire Specific (BMQ) and the Belief Medicine Questionnaire General (BMQ), the Brief Illness Perception Questionnaire (BIPQ), the Oxford COVID-19 Vaccine Hesitancy Scale, and the Bespoke scale [<xref rid="B41-vaccines-12-01411" ref-type="bibr">41</xref>].</p></sec><sec id="sec3dot4-vaccines-12-01411"><title>3.4. Vaccination History and Hesitancy</title><p>Regarding vaccination history (<xref rid="vaccines-12-01411-t001" ref-type="table">Table 1</xref>), the majority of HCPs had received at least one dose of the initial COVID-19 vaccine [<xref rid="B22-vaccines-12-01411" ref-type="bibr">22</xref>,<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B41-vaccines-12-01411" ref-type="bibr">41</xref>,<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>,<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>,<xref rid="B55-vaccines-12-01411" ref-type="bibr">55</xref>,<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>,<xref rid="B58-vaccines-12-01411" ref-type="bibr">58</xref>,<xref rid="B59-vaccines-12-01411" ref-type="bibr">59</xref>,<xref rid="B60-vaccines-12-01411" ref-type="bibr">60</xref>,<xref rid="B61-vaccines-12-01411" ref-type="bibr">61</xref>,<xref rid="B62-vaccines-12-01411" ref-type="bibr">62</xref>]. The percentages of HCPs receiving booster vaccinations have been found to vary widely in studies, with reported rates ranging from 4.9% to 100%. More specifically, the first BD has been administered to a considerable percentage of HCPs [<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B55-vaccines-12-01411" ref-type="bibr">55</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>,<xref rid="B58-vaccines-12-01411" ref-type="bibr">58</xref>,<xref rid="B59-vaccines-12-01411" ref-type="bibr">59</xref>,<xref rid="B60-vaccines-12-01411" ref-type="bibr">60</xref>,<xref rid="B61-vaccines-12-01411" ref-type="bibr">61</xref>,<xref rid="B62-vaccines-12-01411" ref-type="bibr">62</xref>], while a smaller proportion have received the second BD [<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B41-vaccines-12-01411" ref-type="bibr">41</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>,<xref rid="B58-vaccines-12-01411" ref-type="bibr">58</xref>,<xref rid="B62-vaccines-12-01411" ref-type="bibr">62</xref>]. The number of HCPs who have received the third BD is even lower [<xref rid="B41-vaccines-12-01411" ref-type="bibr">41</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>]. There were substantial variations in HCPs&#x02019; hesitancy towards BDs, ranging from 12% to 66.5% [<xref rid="B22-vaccines-12-01411" ref-type="bibr">22</xref>,<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>,<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>,<xref rid="B58-vaccines-12-01411" ref-type="bibr">58</xref>,<xref rid="B59-vaccines-12-01411" ref-type="bibr">59</xref>]. Hesitancy rates varied significantly across continents, with Asia ranging from 19.7% to 66.5%, Africa from 27% to 46.1%, and Europe from 14% to 60.2%. From the highest to the lowest rates of booster dose vaccination hesitancy, the countries were Palestine at 66.5% [<xref rid="B22-vaccines-12-01411" ref-type="bibr">22</xref>], Israel at 61.3% [<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>], Greece with rates ranging from 30.9 to 52.9% [<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>], Italy with rates ranging from 51.9% to 60.2%) [<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>], Egypt at 46.1% [<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>], Congo at 31.1% [<xref rid="B58-vaccines-12-01411" ref-type="bibr">58</xref>], Pakistan at 24.2% [<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>], South Africa at 20% [<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>], Malysia at 22% [<xref rid="B59-vaccines-12-01411" ref-type="bibr">59</xref>], South India at 19.7% [<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>], Jordan at 16% [<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>], Belgium at 14% [<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>], and Nepal at 12% [<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>]. Physicians displayed the most diverse hesitancy rates, ranging from 12.8% to 43.7%, whereas nurses and pharmacists exhibited rates between 26% and 37% and 26% to 34.6%, respectively.</p></sec><sec id="sec3dot5-vaccines-12-01411"><title>3.5. Socio-Demographic Characteristics and COVID-19-Related Variables Associated with Vaccination Hesitancy</title><p>Socio-demographic characteristics related to vaccine booster dose hesitancy in HCPs were gender, age, type of HCPs included in studies, marital status, education level, co-morbidities, type of vaccine, and not being regularly vaccinated against influenza [<xref rid="B22-vaccines-12-01411" ref-type="bibr">22</xref>,<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>,<xref rid="B55-vaccines-12-01411" ref-type="bibr">55</xref>,<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>,<xref rid="B58-vaccines-12-01411" ref-type="bibr">58</xref>,<xref rid="B59-vaccines-12-01411" ref-type="bibr">59</xref>,<xref rid="B60-vaccines-12-01411" ref-type="bibr">60</xref>,<xref rid="B62-vaccines-12-01411" ref-type="bibr">62</xref>] (<xref rid="vaccines-12-01411-t002" ref-type="table">Table 2</xref>). When it comes to gender differences, females exhibited greater hesitancy towards receiving BDs than males [<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>,<xref rid="B60-vaccines-12-01411" ref-type="bibr">60</xref>]. Additionally, individuals without a chronic condition [<xref rid="B33-vaccines-12-01411" ref-type="bibr">33</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B58-vaccines-12-01411" ref-type="bibr">58</xref>,<xref rid="B60-vaccines-12-01411" ref-type="bibr">60</xref>] and without medical training demonstrated a lower willingness compared to medical professionals to receive BDs [<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>,<xref rid="B58-vaccines-12-01411" ref-type="bibr">58</xref>]. Being in a younger age range [<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B55-vaccines-12-01411" ref-type="bibr">55</xref>,<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>,<xref rid="B60-vaccines-12-01411" ref-type="bibr">60</xref>,<xref rid="B62-vaccines-12-01411" ref-type="bibr">62</xref>], being single [<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>], and having a lower level of education [<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B62-vaccines-12-01411" ref-type="bibr">62</xref>] were also all factors that were positively associated with vaccine hesitancy. Family and friends were also identified as influential factors contributing to hesitancy [<xref rid="B41-vaccines-12-01411" ref-type="bibr">41</xref>,<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>,<xref rid="B58-vaccines-12-01411" ref-type="bibr">58</xref>]. On the other hand, individuals who had received mRNA-based vaccines in the past [<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>] and regularly received influenza vaccinations [<xref rid="B22-vaccines-12-01411" ref-type="bibr">22</xref>,<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B55-vaccines-12-01411" ref-type="bibr">55</xref>,<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>] were more inclined to be receptive to receiving a booster vaccine dose.</p></sec><sec id="sec3dot6-vaccines-12-01411"><title>3.6. Vaccination Knowledge and Attitudes</title><p>In relation to vaccination attitudes, a notable percentage of HCPs (ranging from 6% to 77.1%) held the belief that the currently available BDs were not required, deemed unsafe, and lacked effectiveness [<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>,<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>,<xref rid="B58-vaccines-12-01411" ref-type="bibr">58</xref>] (<xref rid="vaccines-12-01411-t003" ref-type="table">Table 3</xref>). Furthermore, their belief was that vaccines do not provide adequate protection against severe cases of COVID-19 [<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>,<xref rid="B59-vaccines-12-01411" ref-type="bibr">59</xref>]. Consequently, there was a lack of trust in these vaccines, with percentages ranging from 20.9% to 26.8%. [<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>]. Fear of the side effects associated with COVID-19 booster vaccinations, [<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>], a belief in a low risk of COVID-19 infection [<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>], the non-compulsory nature of booster doses [<xref rid="B41-vaccines-12-01411" ref-type="bibr">41</xref>,<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>,<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>,<xref rid="B59-vaccines-12-01411" ref-type="bibr">59</xref>], and a history of COVID-19 infection [<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>] were also identified as contributing factors for vaccine hesitancy. Nevertheless, it seems that HCPs acknowledged receiving information about the efficacy of COVID-19 BDs [<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>], and expressed their willingness to receive additional information [<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>].</p></sec></sec><sec sec-type="discussion" id="sec4-vaccines-12-01411"><title>4. Discussion</title><p>The objective of this scoping review was to evaluate the hesitancy of HCPs towards vaccination with COVID-19 BDs and identify associated factors. Our findings suggest that HCPs exhibit varying degrees of hesitancy across countries, indicating that HCPs still had concerns related to BDs. This hesitancy leads to a progressive decrease in the percentage of HCPs receiving the second and third booster doses. The prevalence of hesitancy towards BDs in HCPs was higher among females, younger and single individuals, those with lower education levels, and those who did not regularly receive flu vaccines. Notably, individuals with a history of COVID-19 infection, without chronic conditions, and non-physician HCPs also exhibited hesitancy. This review also identified the following key factors that prominently influenced BD hesitancy: uncertainties surrounding the vaccine&#x02019;s safety, efficacy, and necessity, a perception of low risk of contracting the infection, and that BDs were not mandatory.</p><p>In light of the evolving virus and the appearance of new variants, health authorities have endorsed the regular utilization of BDs to enhance and prolong vaccine-induced immunity [<xref rid="B8-vaccines-12-01411" ref-type="bibr">8</xref>,<xref rid="B9-vaccines-12-01411" ref-type="bibr">9</xref>,<xref rid="B10-vaccines-12-01411" ref-type="bibr">10</xref>]. However, our review indicates that a considerable portion of HCPs remain hesitant in receiving BDs of the COVID-19 vaccine. Literature research on vaccine hesitancy for COVID-19 in HCPs has produced varied results [<xref rid="B63-vaccines-12-01411" ref-type="bibr">63</xref>]. While HCPs generally exhibit lower vaccine hesitancy compared to non-healthcare workers [<xref rid="B63-vaccines-12-01411" ref-type="bibr">63</xref>], some studies have found no significant differences in vaccine hesitancy between these two groups [<xref rid="B64-vaccines-12-01411" ref-type="bibr">64</xref>,<xref rid="B65-vaccines-12-01411" ref-type="bibr">65</xref>]. Furthermore, the underlying factors contributing to vaccination hesitancy among HCPs appear to be similar to those documented within the general population [<xref rid="B66-vaccines-12-01411" ref-type="bibr">66</xref>]. This raises concerns since HCPs have traditionally been the primary and most trustworthy source of vaccine information [<xref rid="B67-vaccines-12-01411" ref-type="bibr">67</xref>]. It is to be expected that HCPs who have not been vaccinated are much less likely to suggest vaccinations to their patients [<xref rid="B31-vaccines-12-01411" ref-type="bibr">31</xref>]. However, even HCPs who have received their vaccinations need access to continually updated resources to effectively address vaccine hesitancy and discuss vaccines with their patients [<xref rid="B31-vaccines-12-01411" ref-type="bibr">31</xref>,<xref rid="B68-vaccines-12-01411" ref-type="bibr">68</xref>].</p><p>Another important finding of our review was the substantial variability in the hesitancy levels of HCPs across various countries. The COVID-19 vaccination hesitancy rates in Jordan at 16% [<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>], Belgium at 14% [<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>], and Nepal at 12% [<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>] were among the lowest worldwide, which could be attributed to significant efforts to build public trust in vaccines [<xref rid="B69-vaccines-12-01411" ref-type="bibr">69</xref>]. On the other hand, Palestine at 66.5% [<xref rid="B22-vaccines-12-01411" ref-type="bibr">22</xref>] and Israel at 61.3% [<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>] had the highest hesitancy rates. This variability aligns not only with other previous reviews conducted during the primary COVID-19 vaccination campaigns [<xref rid="B12-vaccines-12-01411" ref-type="bibr">12</xref>,<xref rid="B70-vaccines-12-01411" ref-type="bibr">70</xref>,<xref rid="B71-vaccines-12-01411" ref-type="bibr">71</xref>,<xref rid="B72-vaccines-12-01411" ref-type="bibr">72</xref>], but also with a subsequent review following the introduction of BDs [<xref rid="B23-vaccines-12-01411" ref-type="bibr">23</xref>]. Socioeconomic factors, such as race and income, are also significantly linked to geographic disparities in vaccine hesitancy [<xref rid="B73-vaccines-12-01411" ref-type="bibr">73</xref>]. A study analyzing COVID-19 vaccine hesitancy across 145 countries highlighted that hesitancy towards vaccination was a more prominent factor in determining uptake in low-income countries compared to high-income countries [<xref rid="B74-vaccines-12-01411" ref-type="bibr">74</xref>]. Lower availability or limited accessibility to COVID-19 vaccines [<xref rid="B75-vaccines-12-01411" ref-type="bibr">75</xref>,<xref rid="B76-vaccines-12-01411" ref-type="bibr">76</xref>], along with higher rates of COVID-19-related morbidity and mortality [<xref rid="B70-vaccines-12-01411" ref-type="bibr">70</xref>] in certain countries, may potentially explain the differences in hesitancy across countries regarding BD vaccinations. The widespread implementation of mandatory primary vaccinations for HCPs [<xref rid="B77-vaccines-12-01411" ref-type="bibr">77</xref>,<xref rid="B78-vaccines-12-01411" ref-type="bibr">78</xref>], and the resulting pressure to vaccinate, may also have contributed to hesitancy [<xref rid="B77-vaccines-12-01411" ref-type="bibr">77</xref>,<xref rid="B79-vaccines-12-01411" ref-type="bibr">79</xref>]. Nevertheless, and despite this considerable variation in hesitancy among HCPs worldwide, it is crucial to recognize the importance of implementing interventions that are tailored to each country&#x02019;s socioeconomical [<xref rid="B80-vaccines-12-01411" ref-type="bibr">80</xref>,<xref rid="B81-vaccines-12-01411" ref-type="bibr">81</xref>,<xref rid="B82-vaccines-12-01411" ref-type="bibr">82</xref>] and even religious conditions [<xref rid="B83-vaccines-12-01411" ref-type="bibr">83</xref>].</p><p>A major finding of the present study was that HCPs continue to express concerns about the vaccine&#x02019;s safety, necessity, and effectiveness, which are the same concerns that contributed to hesitancy towards the initial doses of the COVID-19 vaccine [<xref rid="B12-vaccines-12-01411" ref-type="bibr">12</xref>,<xref rid="B70-vaccines-12-01411" ref-type="bibr">70</xref>]. More specifically, HCPs have expressed concerns about negative effects of multiple boosters on the immune system [<xref rid="B84-vaccines-12-01411" ref-type="bibr">84</xref>,<xref rid="B85-vaccines-12-01411" ref-type="bibr">85</xref>], adverse events (AEs) and serious adverse events (SAEs) including myocarditis and pericarditis, particularly in younger males who have received mRNA vaccines [<xref rid="B86-vaccines-12-01411" ref-type="bibr">86</xref>,<xref rid="B87-vaccines-12-01411" ref-type="bibr">87</xref>]. There are also other rare but serious conditions, such as thrombosis with thrombocytopenia syndrome, that have contributed to unease among HCPs [<xref rid="B88-vaccines-12-01411" ref-type="bibr">88</xref>,<xref rid="B89-vaccines-12-01411" ref-type="bibr">89</xref>,<xref rid="B90-vaccines-12-01411" ref-type="bibr">90</xref>]. Although these AEs are statistically rare compared to the severe outcomes of COVID-19 infection (without a booster dose), they could have a significant impact on how HCPs perceive BDs [<xref rid="B91-vaccines-12-01411" ref-type="bibr">91</xref>,<xref rid="B92-vaccines-12-01411" ref-type="bibr">92</xref>,<xref rid="B93-vaccines-12-01411" ref-type="bibr">93</xref>,<xref rid="B94-vaccines-12-01411" ref-type="bibr">94</xref>,<xref rid="B95-vaccines-12-01411" ref-type="bibr">95</xref>]. To address these concerns and rebuild trust among HCPs, it is crucial to have transparent risk communication strategies and robust post-vaccine safety monitoring in place [<xref rid="B96-vaccines-12-01411" ref-type="bibr">96</xref>,<xref rid="B97-vaccines-12-01411" ref-type="bibr">97</xref>]. In support of this, evidence suggests that HCPs often express a desire for more convincing and comprehensive evidence, in terms of both quality and quantity, when deciding on vaccinations and whether to recommend them [<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B98-vaccines-12-01411" ref-type="bibr">98</xref>,<xref rid="B99-vaccines-12-01411" ref-type="bibr">99</xref>]. This emphasizes the necessity of ongoing training programs that focus on vaccine research, safety data, and effective communication strategies.</p><p>On the other hand, the belief that BDs of the COVID-19 vaccines are inadequate in providing protection against severe forms of COVID-19, as well as the lack of confidence in these vaccines, were also found to be significant factors contributing to vaccine hesitancy. Previous studies confirm these findings, since negative attitudes towards vaccines, lack of trust in government and institutions, and the belief that personal rights are being violated are all indicated as contributing factors to vaccine hesitancy [<xref rid="B12-vaccines-12-01411" ref-type="bibr">12</xref>,<xref rid="B80-vaccines-12-01411" ref-type="bibr">80</xref>]. Another important factor noted is the declining effectiveness of COVID-19 vaccines against infection as time goes on. Research has shown that vaccine-induced immunity, especially against new variants like Omicron, starts to decrease around five months following vaccination, after which &#x0201c;breakthrough&#x0201d; infections could occur [<xref rid="B100-vaccines-12-01411" ref-type="bibr">100</xref>]. Although breakthrough infections during this period are mostly mild, they have raised doubts about the long-term efficacy of BDs, especially for high-exposure groups like HCPs [<xref rid="B100-vaccines-12-01411" ref-type="bibr">100</xref>,<xref rid="B101-vaccines-12-01411" ref-type="bibr">101</xref>]. Behavioral science research indicates that deeper understanding has a stronger influence on decision making than statistical information, even among experts in the field [<xref rid="B102-vaccines-12-01411" ref-type="bibr">102</xref>]. This involves initiating a constructive dialogue, understanding the issues raised from the HCPs [<xref rid="B103-vaccines-12-01411" ref-type="bibr">103</xref>].</p><p>This review also found differences in vaccine hesitancy influenced by sociodemographic and medical history characteristics. More specifically, we found that characteristics such as female gender, lack of comorbidities, younger age, lower levels of education, being single, race/ethnicity (Blacks, Hispanics), and HCPs other than physician, have been identified as potential factors of vaccine hesitancy [<xref rid="B25-vaccines-12-01411" ref-type="bibr">25</xref>,<xref rid="B26-vaccines-12-01411" ref-type="bibr">26</xref>,<xref rid="B27-vaccines-12-01411" ref-type="bibr">27</xref>,<xref rid="B28-vaccines-12-01411" ref-type="bibr">28</xref>,<xref rid="B29-vaccines-12-01411" ref-type="bibr">29</xref>,<xref rid="B30-vaccines-12-01411" ref-type="bibr">30</xref>]. Consistent with prior research [<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>], female gender was identified as a key demographic factor contributing to hesitancy towards booster dose vaccination. In the past, women have shown more hesitancy towards receiving vaccinations for other diseases in comparison to men, and this tendency may also apply to the COVID-19 vaccine [<xref rid="B104-vaccines-12-01411" ref-type="bibr">104</xref>,<xref rid="B105-vaccines-12-01411" ref-type="bibr">105</xref>]. There are two main reasons for this. Firstly, the majority of reported side effects from the COVID-19 vaccine were observed in females, and secondly, women expressed concerns about the vaccine&#x02019;s potential impact on fertility [<xref rid="B105-vaccines-12-01411" ref-type="bibr">105</xref>,<xref rid="B106-vaccines-12-01411" ref-type="bibr">106</xref>,<xref rid="B107-vaccines-12-01411" ref-type="bibr">107</xref>,<xref rid="B108-vaccines-12-01411" ref-type="bibr">108</xref>]. Importantly, having underlying health conditions also appears to be a factor in determining vaccine acceptance. In addition, it seemed that younger HCPs, who tended to have lower levels of education and no flu vaccination in the previous season showed a greater tendency towards being hesitant about BDs. On the other hand, there is a scarcity of studies that have focused on the contribution of different types of healthcare personnel to the reception of COVID-19 BDs. The findings of this review indicate that HCPs displayed varying levels of hesitancy towards COVID-19 vaccination, with non-physicians exhibiting higher levels of hesitancy compared to physicians.</p><p>Finally, it is important to consider that given the unique characteristics of the COVID-19 virus, achieving herd immunity through widespread vaccination presents significant challenges [<xref rid="B109-vaccines-12-01411" ref-type="bibr">109</xref>,<xref rid="B110-vaccines-12-01411" ref-type="bibr">110</xref>]. This is because COVID-19 has the ability to infect various animal reservoirs, including minks, deer, and rodents [<xref rid="B111-vaccines-12-01411" ref-type="bibr">111</xref>,<xref rid="B112-vaccines-12-01411" ref-type="bibr">112</xref>,<xref rid="B113-vaccines-12-01411" ref-type="bibr">113</xref>]. From this point of view, it becomes clear that the health of humans is intimately tied to the health of domestic, wild, and farmed animals [<xref rid="B111-vaccines-12-01411" ref-type="bibr">111</xref>,<xref rid="B112-vaccines-12-01411" ref-type="bibr">112</xref>,<xref rid="B113-vaccines-12-01411" ref-type="bibr">113</xref>]. Therefore, addressing COVID-19 requires a more holistic and internationally coordinated strategy, involving collaboration among diverse disciplines like medicine and veterinary medicine. This effort should be guided by the &#x0201c;One Health&#x0201d; concept, recognizing the inherent interconnectedness between human and animal health, and the ecosystem [<xref rid="B114-vaccines-12-01411" ref-type="bibr">114</xref>].</p><sec><title>Limitations</title><p>Our review makes a valuable contribution to the existing literature by thoroughly investigating the factors behind HCPs&#x02019; hesitancy towards COVID-19 booster dose vaccination. Nevertheless, it is essential to recognize certain limitations as well. To begin with, we exclusively examined articles published in English, thereby narrowing down the selection of eligible studies. Moreover, the studies we selected were drawn from different contexts and populations, which posed challenges in terms of making comparisons and conducting further analysis. The majority of studies have also used self-reported surveys, increasing the likelihood of response bias. Differences in reported vaccine hesitancy across countries could also be partly explained by variations in measurement techniques, including the use of different survey questions or assessment tools. Furthermore, as real-world data emerge, we should anticipate potential changes in HCPs&#x02019; views on COVID-19 vaccines. Longitudinal studies could offer valuable information about the evolving nature of attitudes in light of new developments and face-to-face interviews and focus groups could offer valuable insights into their beliefs and concerns that might not be captured by previous studies. Lastly, it should be noted that no evaluation was conducted on the articles&#x02019; quality, and the conclusions were simply summarized without any supplementary analysis.</p></sec></sec><sec sec-type="conclusions" id="sec5-vaccines-12-01411"><title>5. Conclusions</title><p>In summary, our review underscores the hesitancy among healthcare professionals (HCPs) towards receiving booster doses of the COVID-19 vaccine despite receiving the initial dose of the COVID-19 vaccine. This hesitancy is primarily influenced by sociodemographic factors and concerns surrounding vaccine safety, necessity, and effectiveness. Gaining insight into these factors underlying this hesitancy could guide future vaccination approaches. To better understand the nuances of vaccine knowledge, attitudes, and behaviors, future research should adopt a longitudinal qualitative approach to examine variations across time and regions with new developments.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-vaccines-12-01411"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/vaccines12121411/s1">https://www.mdpi.com/article/10.3390/vaccines12121411/s1</uri>, Table S1: Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist.</p><supplementary-material id="vaccines-12-01411-s001" position="float" content-type="local-data"><media xlink:href="vaccines-12-01411-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, A.C., I.B., A.A.-K., M.Z.-S. and I.T.; methodology, A.C., I.B., A.A.-K., M.Z.-S. and I.T.; formal analysis, A.C., I.B., A.A.-K., M.Z.-S. and I.T.; resources, A.C., I.B. and A.A.-K.; writing&#x02014;original draft preparation, A.C., I.B. and A.A.-K.; writing&#x02014;review and editing, A.C., I.B., A.A.-K., M.Z.-S. and I.T.; supervision, I.T. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-vaccines-12-01411"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ashmore</surname><given-names>P.</given-names></name>
<name><surname>Sherwood</surname><given-names>E.</given-names></name>
</person-group><article-title>An overview of COVID-19 global epidemiology and discussion of potential drivers of variable global pandemic impacts</article-title><source>J. Antimicrob. Chemother.</source><year>2023</year><volume>78</volume><fpage>ii2</fpage><lpage>ii11</lpage><pub-id pub-id-type="doi">10.1093/jac/dkad311</pub-id><pub-id pub-id-type="pmid">37995358</pub-id>
</element-citation></ref><ref id="B2-vaccines-12-01411"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hodgson</surname><given-names>S.H.</given-names></name>
<name><surname>Mansatta</surname><given-names>K.</given-names></name>
<name><surname>Mallett</surname><given-names>G.</given-names></name>
<name><surname>Harris</surname><given-names>V.</given-names></name>
<name><surname>Emary</surname><given-names>K.R.W.</given-names></name>
<name><surname>Pollard</surname><given-names>A.J.</given-names></name>
</person-group><article-title>What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2</article-title><source>Lancet Infect. Dis.</source><year>2021</year><volume>21</volume><fpage>e26</fpage><lpage>e35</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30773-8</pub-id><pub-id pub-id-type="pmid">33125914</pub-id>
</element-citation></ref><ref id="B3-vaccines-12-01411"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adebisi</surname><given-names>Y.A.</given-names></name>
<name><surname>Alaran</surname><given-names>A.J.</given-names></name>
<name><surname>Bolarinwa</surname><given-names>O.A.</given-names></name>
<name><surname>Akande-Sholabi</surname><given-names>W.</given-names></name>
<name><surname>Lucero-Prisno</surname><given-names>D.E.</given-names></name>
</person-group><article-title>When it is available, will we take it? Social media users&#x02019; perception of hypothetical COVID-19 vaccine in Nigeria</article-title><source>Pan Afr. Med. J.</source><year>2021</year><volume>38</volume><fpage>230</fpage><pub-id pub-id-type="doi">10.11604/pamj.2021.38.230.27325</pub-id><pub-id pub-id-type="pmid">34046135</pub-id>
</element-citation></ref><ref id="B4-vaccines-12-01411"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Gier</surname><given-names>B.</given-names></name>
<name><surname>van Asten</surname><given-names>L.</given-names></name>
<name><surname>Boere</surname><given-names>T.M.</given-names></name>
<name><surname>van Roon</surname><given-names>A.</given-names></name>
<name><surname>van Roekel</surname><given-names>C.</given-names></name>
<name><surname>Pijpers</surname><given-names>J.</given-names></name>
<name><surname>van Werkhoven</surname><given-names>C.H.H.</given-names></name>
<name><surname>van den Ende</surname><given-names>C.</given-names></name>
<name><surname>Hahn&#x000e9;</surname><given-names>S.J.M.</given-names></name>
<name><surname>de Melker</surname><given-names>H.E.</given-names></name>
<etal/>
</person-group><article-title>Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021&#x02013;January 2022</article-title><source>Vaccine</source><year>2023</year><volume>41</volume><fpage>4488</fpage><lpage>4496</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2023.06.005</pub-id><pub-id pub-id-type="pmid">37328352</pub-id>
</element-citation></ref><ref id="B5-vaccines-12-01411"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wouters</surname><given-names>O.J.</given-names></name>
<name><surname>Shadlen</surname><given-names>K.C.</given-names></name>
<name><surname>Salcher-Konrad</surname><given-names>M.</given-names></name>
<name><surname>Pollard</surname><given-names>A.J.</given-names></name>
<name><surname>Larson</surname><given-names>H.J.</given-names></name>
<name><surname>Teerawattananon</surname><given-names>Y.</given-names></name>
<name><surname>Jit</surname><given-names>M.</given-names></name>
</person-group><article-title>Challenges in ensuring global access to COVID-19 vaccines: Production, affordability, allocation, and deployment</article-title><source>Lancet</source><year>2021</year><volume>397</volume><fpage>1023</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)00306-8</pub-id><pub-id pub-id-type="pmid">33587887</pub-id>
</element-citation></ref><ref id="B6-vaccines-12-01411"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Harder</surname><given-names>T.</given-names></name>
<name><surname>Koch</surname><given-names>J.</given-names></name>
<name><surname>Vygen-Bonnet</surname><given-names>S.</given-names></name>
<name><surname>K&#x000fc;lper-Schiek</surname><given-names>W.</given-names></name>
<name><surname>Pilic</surname><given-names>A.</given-names></name>
<name><surname>Reda</surname><given-names>S.</given-names></name>
<name><surname>Scholz</surname><given-names>S.</given-names></name>
<name><surname>Wichmann</surname><given-names>O.</given-names></name>
</person-group><article-title>Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: Interim results of a living systematic review, 1 January to 14 May 2021</article-title><source>Eurosurveillance</source><year>2021</year><volume>26</volume><fpage>2100563</fpage><pub-id pub-id-type="doi">10.2807/1560-7917.ES.2021.26.28.2100563</pub-id><pub-id pub-id-type="pmid">34269175</pub-id>
</element-citation></ref><ref id="B7-vaccines-12-01411"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chakraborty</surname><given-names>C.</given-names></name>
<name><surname>Bhattacharya</surname><given-names>M.</given-names></name>
<name><surname>Dhama</surname><given-names>K.</given-names></name>
</person-group><article-title>SARS-CoV-2 vaccines, vaccine development technologies, and significant efforts in vaccine development during the pandemic: The lessons learned might help to fight against the next pandemic</article-title><source>Vaccines</source><year>2023</year><volume>11</volume><elocation-id>682</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines11030682</pub-id><pub-id pub-id-type="pmid">36992266</pub-id>
</element-citation></ref><ref id="B8-vaccines-12-01411"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wu</surname><given-names>N.</given-names></name>
<name><surname>Joyal-Desmarais</surname><given-names>K.</given-names></name>
<name><surname>Ribeiro</surname><given-names>P.A.B.</given-names></name>
<name><surname>Vieira</surname><given-names>A.M.</given-names></name>
<name><surname>Stojanovic</surname><given-names>J.</given-names></name>
<name><surname>Sanuade</surname><given-names>C.</given-names></name>
<name><surname>Yip</surname><given-names>D.</given-names></name>
<name><surname>Bacon</surname><given-names>S.L.</given-names></name>
</person-group><article-title>Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: Findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022</article-title><source>Lancet Respir. Med.</source><year>2023</year><volume>11</volume><fpage>439</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(23)00015-2</pub-id><pub-id pub-id-type="pmid">36780914</pub-id>
</element-citation></ref><ref id="B9-vaccines-12-01411"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Naaber</surname><given-names>P.</given-names></name>
<name><surname>Tserel</surname><given-names>L.</given-names></name>
<name><surname>Kangro</surname><given-names>K.</given-names></name>
<name><surname>Sepp</surname><given-names>E.</given-names></name>
<name><surname>J&#x000fc;rjenson</surname><given-names>V.</given-names></name>
<name><surname>Adamson</surname><given-names>A.</given-names></name>
<name><surname>Haljasm&#x000e4;gi</surname><given-names>L.</given-names></name>
<name><surname>Rumm</surname><given-names>A.P.</given-names></name>
<name><surname>Maruste</surname><given-names>R.</given-names></name>
<name><surname>K&#x000e4;rner</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Dynamics of antibody response to BNT162b2 vaccine after six months: A longitudinal prospective study</article-title><source>Lancet Reg. Health Eur.</source><year>2021</year><volume>10</volume><fpage>100208</fpage><pub-id pub-id-type="doi">10.1016/j.lanepe.2021.100208</pub-id><pub-id pub-id-type="pmid">34514454</pub-id>
</element-citation></ref><ref id="B10-vaccines-12-01411"><label>10.</label><element-citation publication-type="webpage"><person-group person-group-type="author">
<collab>World Health Organization (WHO)</collab>
</person-group><article-title>Vaccine Efficacy, Effectiveness and Protection</article-title><comment>Available online: <ext-link xlink:href="https://www.who.int/news-room/feature-stories/detail/vaccine-efficacy-effectiveness-and-protection" ext-link-type="uri">https://www.who.int/news-room/feature-stories/detail/vaccine-efficacy-effectiveness-and-protection</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-06-20">(accessed on 20 June 2024)</date-in-citation></element-citation></ref><ref id="B11-vaccines-12-01411"><label>11.</label><element-citation publication-type="webpage"><person-group person-group-type="author">
<collab>World Health Organization (WHO)</collab>
</person-group><article-title>WHO SAGE Roadmap on Uses of COVID-19 Vaccines in the Context of OMICRON and Substantial Population Immunity</article-title><comment>Available online: <ext-link xlink:href="https://iris.who.int/handle/10665/366671" ext-link-type="uri">https://iris.who.int/handle/10665/366671</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-04-14">(accessed on 14 April 2024)</date-in-citation></element-citation></ref><ref id="B12-vaccines-12-01411"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Peterson</surname><given-names>C.J.</given-names></name>
<name><surname>Lee</surname><given-names>B.</given-names></name>
<name><surname>Nugent</surname><given-names>K.</given-names></name>
</person-group><article-title>COVID-19 Vaccination Hesitancy among Healthcare Workers&#x02014;A Review</article-title><source>Vaccines</source><year>2022</year><volume>10</volume><elocation-id>948</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines10060948</pub-id><pub-id pub-id-type="pmid">35746556</pub-id>
</element-citation></ref><ref id="B13-vaccines-12-01411"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Razai</surname><given-names>M.S.</given-names></name>
<name><surname>Oakeshott</surname><given-names>P.</given-names></name>
<name><surname>Esmail</surname><given-names>A.</given-names></name>
<name><surname>Wiysonge</surname><given-names>C.S.</given-names></name>
<name><surname>Viswanath</surname><given-names>K.</given-names></name>
<name><surname>Mills</surname><given-names>M.C.</given-names></name>
</person-group><article-title>COVID-19 vaccine hesitancy: The five Cs to tackle behavioural and sociodemographic factors</article-title><source>J. R. Soc. Med.</source><year>2021</year><volume>114</volume><fpage>295</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1177/01410768211018951</pub-id><pub-id pub-id-type="pmid">34077688</pub-id>
</element-citation></ref><ref id="B14-vaccines-12-01411"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>L.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Cheng</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
</person-group><article-title>Acceptance of coronavirus disease 2019 (COVID-19) vaccines among healthcare workers: A meta-analysis</article-title><source>Front. Public Health</source><year>2022</year><volume>10</volume><elocation-id>881903</elocation-id><pub-id pub-id-type="doi">10.3389/fpubh.2022.881903</pub-id><pub-id pub-id-type="pmid">36187624</pub-id>
</element-citation></ref><ref id="B15-vaccines-12-01411"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>C.</given-names></name>
<name><surname>Mullen</surname><given-names>J.</given-names></name>
<name><surname>Smith</surname><given-names>D.</given-names></name>
<name><surname>Kotarba</surname><given-names>M.</given-names></name>
<name><surname>Kaplan</surname><given-names>S.J.</given-names></name>
<name><surname>Tu</surname><given-names>P.</given-names></name>
</person-group><article-title>Healthcare Providers&#x02019; Vaccine Perceptions, Hesitancy, and Recommendation to Patients: A Systematic Review</article-title><source>Vaccines</source><year>2021</year><volume>9</volume><elocation-id>713</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines9070713</pub-id><pub-id pub-id-type="pmid">34358132</pub-id>
</element-citation></ref><ref id="B16-vaccines-12-01411"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ramonfaur</surname><given-names>D.</given-names></name>
<name><surname>Limaye</surname><given-names>R.J.</given-names></name>
<name><surname>Hinojosa-Gonz&#x000e1;lez</surname><given-names>D.E.</given-names></name>
<name><surname>Barrera</surname><given-names>F.J.</given-names></name>
<name><surname>Rodr&#x000ed;guez-G&#x000f3;mez</surname><given-names>G.P.</given-names></name>
<name><surname>Castillo-Salgado</surname><given-names>C.</given-names></name>
</person-group><article-title>COVID-19 vaccine hesitancy prevalence in Mexico: A systematic review and metanalysis</article-title><source>Vaccine X</source><year>2024</year><volume>18</volume><fpage>100488</fpage><pub-id pub-id-type="doi">10.1016/j.jvacx.2024.100488</pub-id><pub-id pub-id-type="pmid">38699155</pub-id>
</element-citation></ref><ref id="B17-vaccines-12-01411"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rahbeni</surname><given-names>T.A.</given-names></name>
<name><surname>Satapathy</surname><given-names>P.</given-names></name>
<name><surname>Itumalla</surname><given-names>R.</given-names></name>
<name><surname>Marzo</surname><given-names>R.R.</given-names></name>
<name><surname>Mugheed</surname><given-names>K.A.L.</given-names></name>
<name><surname>Khatib</surname><given-names>M.N.</given-names></name>
<name><surname>Gaidhane</surname><given-names>S.</given-names></name>
<name><surname>Zahiruddin</surname><given-names>Q.S.</given-names></name>
<name><surname>Rabaan</surname><given-names>A.A.</given-names></name>
<name><surname>Alrasheed</surname><given-names>H.A.</given-names></name>
<etal/>
</person-group><article-title>COVID-19 Vaccine Hesitancy: Umbrella Review of Systematic Reviews and Meta-Analysis</article-title><source>JMIR Public Health Surveill.</source><year>2024</year><volume>10</volume><fpage>e54769</fpage><pub-id pub-id-type="doi">10.2196/54769</pub-id><pub-id pub-id-type="pmid">38687992</pub-id>
</element-citation></ref><ref id="B18-vaccines-12-01411"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weinstein</surname><given-names>N.</given-names></name>
<name><surname>Schwarz</surname><given-names>K.</given-names></name>
<name><surname>Chan</surname><given-names>I.</given-names></name>
<name><surname>Kobau</surname><given-names>R.</given-names></name>
<name><surname>Alexander</surname><given-names>R.</given-names></name>
<name><surname>Kollar</surname><given-names>L.</given-names></name>
<name><surname>Rodriguez</surname><given-names>L.</given-names></name>
<name><surname>Mansergh</surname><given-names>G.</given-names></name>
<name><surname>Repetski</surname><given-names>T.</given-names></name>
<name><surname>Gandhi</surname><given-names>P.</given-names></name>
<etal/>
</person-group><article-title>COVID-19 Vaccine Hesitancy Among US Adults: Safety and Effectiveness Perceptions and Messaging to Increase Vaccine Confidence and Intent to Vaccinate</article-title><source>Public Health Rep.</source><year>2024</year><volume>139</volume><fpage>102</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1177/00333549231204419</pub-id><pub-id pub-id-type="pmid">37924246</pub-id>
</element-citation></ref><ref id="B19-vaccines-12-01411"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bhattacharya</surname><given-names>O.</given-names></name>
<name><surname>Siddiquea</surname><given-names>B.N.</given-names></name>
<name><surname>Shetty</surname><given-names>A.</given-names></name>
<name><surname>Afroz</surname><given-names>A.</given-names></name>
<name><surname>Billah</surname><given-names>B.</given-names></name>
</person-group><article-title>COVID-19 vaccine hesitancy among pregnant women: A systematic review and meta-analysis</article-title><source>BMJ Open</source><year>2022</year><volume>12</volume><fpage>e061477</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2022-061477</pub-id></element-citation></ref><ref id="B20-vaccines-12-01411"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ma</surname><given-names>Y.</given-names></name>
<name><surname>Ren</surname><given-names>J.</given-names></name>
<name><surname>Zheng</surname><given-names>Y.</given-names></name>
<name><surname>Cai</surname><given-names>D.</given-names></name>
<name><surname>Li</surname><given-names>S.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
</person-group><article-title>Chinese parents&#x02019; willingness to vaccinate their children against COVID-19: A systematic review and meta-analysis</article-title><source>Front. Public Health</source><year>2022</year><volume>10</volume><elocation-id>1087295</elocation-id><pub-id pub-id-type="doi">10.3389/fpubh.2022.1087295</pub-id><pub-id pub-id-type="pmid">36590001</pub-id>
</element-citation></ref><ref id="B21-vaccines-12-01411"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Burrowes</surname><given-names>S.A.B.</given-names></name>
<name><surname>Casey</surname><given-names>S.M.</given-names></name>
<name><surname>Dobbins</surname><given-names>S.</given-names></name>
<name><surname>Hall</surname><given-names>T.</given-names></name>
<name><surname>Ma</surname><given-names>M.</given-names></name>
<name><surname>Bano</surname><given-names>R.</given-names></name>
<name><surname>Drainoni</surname><given-names>M.L.</given-names></name>
<name><surname>Schechter-Perkins</surname><given-names>E.M.</given-names></name>
<name><surname>Garofalo</surname><given-names>C.</given-names></name>
<name><surname>Perkins</surname><given-names>R.B.</given-names></name>
<etal/>
</person-group><article-title>Healthcare workers&#x02019; perspectives on the COVID-19 vaccine and boosters for themselves, their patients, and their communities: A mixed methods study</article-title><source>J. Public Health</source><year>2024</year><volume>32</volume><fpage>123</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1007/s10389-022-01793-1</pub-id></element-citation></ref><ref id="B22-vaccines-12-01411"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maraqa</surname><given-names>B.</given-names></name>
<name><surname>Nazzal</surname><given-names>Z.</given-names></name>
<name><surname>Baroud</surname><given-names>H.</given-names></name>
<name><surname>Douden</surname><given-names>M.</given-names></name>
<name><surname>El Hamshary</surname><given-names>Y.</given-names></name>
<name><surname>Jalamneh</surname><given-names>T.</given-names></name>
</person-group><article-title>Healthcare workers&#x02019; attitudes toward and factors influencing their acceptance of an annual COVID-19 booster vaccine: A cross-sectional study in Palestine</article-title><source>BMC Health Serv. Res.</source><year>2024</year><volume>24</volume><elocation-id>624</elocation-id><pub-id pub-id-type="doi">10.1186/s12913-024-11016-w</pub-id><pub-id pub-id-type="pmid">38745215</pub-id>
</element-citation></ref><ref id="B23-vaccines-12-01411"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aldakhlan</surname><given-names>H.A.</given-names></name>
<name><surname>Khan</surname><given-names>A.S.</given-names></name>
<name><surname>Alabdulbaqi</surname><given-names>D.</given-names></name>
</person-group><article-title>Hesitancy Over the COVID-19 Vaccine Among Various Healthcare Workers: An International Narrative Review</article-title><source>Cureus</source><year>2024</year><volume>16</volume><fpage>e53059</fpage><pub-id pub-id-type="doi">10.7759/cureus.53059</pub-id><pub-id pub-id-type="pmid">38410316</pub-id>
</element-citation></ref><ref id="B24-vaccines-12-01411"><label>24.</label><element-citation publication-type="webpage"><person-group person-group-type="author">
<collab>European Centre for Disease Prevention and Control (ECDC)</collab>
</person-group><article-title>Vaccine Hesitancy</article-title><comment>Available online: <ext-link xlink:href="https://www.ecdc.europa.eu/en/immunisation-vaccines/vaccine-hesitancy" ext-link-type="uri">https://www.ecdc.europa.eu/en/immunisation-vaccines/vaccine-hesitancy</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-07-10">(accessed on 10 July 2024)</date-in-citation></element-citation></ref><ref id="B25-vaccines-12-01411"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oliver</surname><given-names>K.</given-names></name>
<name><surname>Raut</surname><given-names>A.</given-names></name>
<name><surname>Pierre</surname><given-names>S.</given-names></name>
<name><surname>Silvera</surname><given-names>L.</given-names></name>
<name><surname>Boulos</surname><given-names>A.</given-names></name>
<name><surname>Gale</surname><given-names>A.</given-names></name>
<name><surname>Baum</surname><given-names>A.</given-names></name>
<name><surname>Chory</surname><given-names>A.</given-names></name>
<name><surname>Davis</surname><given-names>N.J.</given-names></name>
<name><surname>D&#x02019;Souza</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Factors associated with COVID-19 vaccine receipt at two integrated healthcare systems in New York City: A cross-sectional study of healthcare workers</article-title><source>BMJ Open</source><year>2022</year><volume>12</volume><fpage>e053641</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2021-053641</pub-id><pub-id pub-id-type="pmid">34992113</pub-id>
</element-citation></ref><ref id="B26-vaccines-12-01411"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Toth-Manikowski</surname><given-names>S.M.</given-names></name>
<name><surname>Swirsky</surname><given-names>E.S.</given-names></name>
<name><surname>Gandhi</surname><given-names>R.</given-names></name>
<name><surname>Piscitello</surname><given-names>G.</given-names></name>
</person-group><article-title>COVID-19 vaccination hesitancy among health care workers, communication, and policy-making</article-title><source>Am. J. Infect. Control.</source><year>2022</year><volume>50</volume><fpage>20</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.ajic.2021.10.004</pub-id><pub-id pub-id-type="pmid">34653527</pub-id>
</element-citation></ref><ref id="B27-vaccines-12-01411"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Q.</given-names></name>
<name><surname>Yang</surname><given-names>L.</given-names></name>
<name><surname>Jin</surname><given-names>H.</given-names></name>
<name><surname>Lin</surname><given-names>L.</given-names></name>
</person-group><article-title>Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors</article-title><source>Prev. Med.</source><year>2021</year><volume>150</volume><fpage>106694</fpage><pub-id pub-id-type="doi">10.1016/j.ypmed.2021.106694</pub-id><pub-id pub-id-type="pmid">34171345</pub-id>
</element-citation></ref><ref id="B28-vaccines-12-01411"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Painter</surname><given-names>E.M.</given-names></name>
<name><surname>Ussery</surname><given-names>E.N.</given-names></name>
<name><surname>Patel</surname><given-names>A.</given-names></name>
<name><surname>Hughes</surname><given-names>M.M.</given-names></name>
<name><surname>Zell</surname><given-names>E.R.</given-names></name>
<name><surname>Moulia</surname><given-names>D.L.</given-names></name>
<name><surname>Scharf</surname><given-names>L.G.</given-names></name>
<name><surname>Lynch</surname><given-names>M.</given-names></name>
<name><surname>Ritchey</surname><given-names>M.D.</given-names></name>
<name><surname>Toblin</surname><given-names>R.L.</given-names></name>
<etal/>
</person-group><article-title>Demographic Characteristics of Persons Vaccinated During the First Month of the COVID-19 Vaccination Program&#x02014;United States, December 14, 2020&#x02013;January 14, 2021</article-title><source>MMWR Morb. Mortal. Wkly. Rep.</source><year>2021</year><volume>70</volume><fpage>174</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm7005e1</pub-id><pub-id pub-id-type="pmid">33539333</pub-id>
</element-citation></ref><ref id="B29-vaccines-12-01411"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Farah</surname><given-names>W.</given-names></name>
<name><surname>Breeher</surname><given-names>L.</given-names></name>
<name><surname>Shah</surname><given-names>V.</given-names></name>
<name><surname>Hainy</surname><given-names>C.</given-names></name>
<name><surname>Tommaso</surname><given-names>C.P.</given-names></name>
<name><surname>Swift</surname><given-names>M.D.</given-names></name>
</person-group><article-title>Disparities in COVID-19 vaccine uptake among health care workers</article-title><source>Vaccine</source><year>2022</year><volume>40</volume><fpage>2749</fpage><lpage>2754</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2022.03.045</pub-id><pub-id pub-id-type="pmid">35361500</pub-id>
</element-citation></ref><ref id="B30-vaccines-12-01411"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>J.T.</given-names></name>
</person-group><article-title>Disparities in COVID-19 vaccination coverage among health care personnel working in long-term care facilities, by job category, National Healthcare Safety Network&#x02014;United States, March 2021</article-title><source>MMWR. Morb. Mortal. Wkly. Rep.</source><year>2021</year><volume>70</volume><fpage>1036</fpage><lpage>1039</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm7030a2</pub-id><pub-id pub-id-type="pmid">34324478</pub-id>
</element-citation></ref><ref id="B31-vaccines-12-01411"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wilpstra</surname><given-names>C.D.</given-names></name>
<name><surname>Morrell</surname><given-names>S.</given-names></name>
<name><surname>Mirza</surname><given-names>N.A.</given-names></name>
<name><surname>Ralph</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Consequences of COVID-19 Vaccine Hesitancy Among Healthcare Providers During the First 10 Months of Vaccine Availability: Scoping Review</article-title><source>Can. J. Nurs. Res.</source><year>2024</year><volume>56</volume><fpage>204</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1177/08445621241251711</pub-id><pub-id pub-id-type="pmid">38693882</pub-id>
</element-citation></ref><ref id="B32-vaccines-12-01411"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wr&#x000f3;blewski</surname><given-names>M.</given-names></name>
<name><surname>Stankowska</surname><given-names>J.</given-names></name>
<name><surname>Kawiak-Jawor</surname><given-names>E.</given-names></name>
</person-group><article-title>&#x02018;We&#x02019;re at war.&#x02019; Healthcare workers&#x02019; experience with organisational change, uncertainty and vaccine hesitancy in 2021 and 2022 during the COVID-19 vaccination programe in Poland</article-title><source>Int. J. Health Plan. Manag.</source><year>2024</year><volume>39</volume><fpage>1298</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.1002/hpm.3801</pub-id></element-citation></ref><ref id="B33-vaccines-12-01411"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Wu</surname><given-names>Y.</given-names></name>
<name><surname>Jing</surname><given-names>S.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Ren</surname><given-names>T.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Dai</surname><given-names>Z.</given-names></name>
<name><surname>Fu</surname><given-names>J.</given-names></name>
<name><surname>Chen</surname><given-names>X.</given-names></name>
<name><surname>Xiao</surname><given-names>W.</given-names></name>
<etal/>
</person-group><article-title>The second dose of COVID-19 vaccine booster hesitancy among health care workers in China: A multicenter cross-sectional study</article-title><source>Am. J. Infect. Control.</source><year>2024</year><volume>52</volume><fpage>525</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1016/j.ajic.2023.11.012</pub-id><pub-id pub-id-type="pmid">38007100</pub-id>
</element-citation></ref><ref id="B34-vaccines-12-01411"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thampy</surname><given-names>P.</given-names></name>
<name><surname>Sharma</surname><given-names>S.</given-names></name>
<name><surname>Joshi</surname><given-names>P.</given-names></name>
<name><surname>Raj</surname><given-names>M.S.</given-names></name>
<name><surname>Rupani</surname><given-names>A.</given-names></name>
<name><surname>Tyagi</surname><given-names>S.</given-names></name>
<name><surname>Joshi</surname><given-names>A.</given-names></name>
</person-group><article-title>COVID-19 Vaccine Hesitancy Among Healthcare Workers: A Phenomenological Study of Skepticism</article-title><source>Cureus</source><year>2024</year><volume>16</volume><fpage>e58445</fpage><pub-id pub-id-type="doi">10.7759/cureus.58445</pub-id><pub-id pub-id-type="pmid">38765453</pub-id>
</element-citation></ref><ref id="B35-vaccines-12-01411"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thaivalappil</surname><given-names>A.</given-names></name>
<name><surname>Young</surname><given-names>I.</given-names></name>
<name><surname>MacKay</surname><given-names>M.</given-names></name>
<name><surname>Pearl</surname><given-names>D.L.</given-names></name>
<name><surname>Papadopoulos</surname><given-names>A.</given-names></name>
</person-group><article-title>A qualitative study exploring healthcare providers&#x02019; and trainees&#x02019; barriers to COVID-19 and influenza vaccine uptake</article-title><source>Health Psychol. Behav. Med.</source><year>2022</year><volume>10</volume><fpage>695</fpage><lpage>712</lpage><pub-id pub-id-type="doi">10.1080/21642850.2022.2106231</pub-id><pub-id pub-id-type="pmid">35957955</pub-id>
</element-citation></ref><ref id="B36-vaccines-12-01411"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bedston</surname><given-names>S.</given-names></name>
<name><surname>Lowthian</surname><given-names>E.</given-names></name>
<name><surname>Jarvis</surname><given-names>C.I.</given-names></name>
<name><surname>Akbari</surname><given-names>A.</given-names></name>
<name><surname>Beggs</surname><given-names>J.</given-names></name>
<name><surname>Bradley</surname><given-names>D.</given-names></name>
<name><surname>de Lusignan</surname><given-names>S.</given-names></name>
<name><surname>Griffiths</surname><given-names>R.</given-names></name>
<name><surname>Herbert</surname><given-names>L.</given-names></name>
<name><surname>Hobbs</surname><given-names>R.</given-names></name>
<etal/>
</person-group><article-title>COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study</article-title><source>Vaccine</source><year>2023</year><volume>41</volume><fpage>1378</fpage><lpage>1389</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2023.01.023</pub-id><pub-id pub-id-type="pmid">36669966</pub-id>
</element-citation></ref><ref id="B37-vaccines-12-01411"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Peters</surname><given-names>M.D.</given-names></name>
<name><surname>Godfrey</surname><given-names>C.</given-names></name>
<name><surname>McInerney</surname><given-names>P.</given-names></name>
<name><surname>Munn</surname><given-names>Z.</given-names></name>
<name><surname>Tricco</surname><given-names>A.C.</given-names></name>
<name><surname>Khalil</surname><given-names>H.</given-names></name>
</person-group><article-title>Chapter 11: Scoping reviews</article-title><source>JBI Man. Evid. Synth.</source><year>2020</year><volume>169</volume><fpage>467</fpage><lpage>473</lpage></element-citation></ref><ref id="B38-vaccines-12-01411"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tricco</surname><given-names>A.C.</given-names></name>
<name><surname>Lillie</surname><given-names>E.</given-names></name>
<name><surname>Zarin</surname><given-names>W.</given-names></name>
<name><surname>O&#x02019;Brien</surname><given-names>K.K.</given-names></name>
<name><surname>Colquhoun</surname><given-names>H.</given-names></name>
<name><surname>Levac</surname><given-names>D.</given-names></name>
<name><surname>Moher</surname><given-names>D.</given-names></name>
<name><surname>Peters</surname><given-names>M.D.J.</given-names></name>
<name><surname>Horsley</surname><given-names>T.</given-names></name>
<name><surname>Weeks</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation</article-title><source>Ann. Intern. Med.</source><year>2018</year><volume>169</volume><fpage>467</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.7326/M18-0850</pub-id><pub-id pub-id-type="pmid">30178033</pub-id>
</element-citation></ref><ref id="B39-vaccines-12-01411"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mak</surname><given-names>S.</given-names></name>
<name><surname>Thomas</surname><given-names>A.</given-names></name>
</person-group><article-title>Steps for Conducting a Scoping Review</article-title><source>J. Grad. Med. Educ.</source><year>2022</year><volume>14</volume><fpage>565</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.4300/JGME-D-22-00621.1</pub-id><pub-id pub-id-type="pmid">36274762</pub-id>
</element-citation></ref><ref id="B40-vaccines-12-01411"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arshad</surname><given-names>M.S.</given-names></name>
<name><surname>Masood</surname><given-names>I.</given-names></name>
<name><surname>Imran</surname><given-names>I.</given-names></name>
<name><surname>Saeed</surname><given-names>H.</given-names></name>
<name><surname>Ahmad</surname><given-names>I.</given-names></name>
<name><surname>Ishaq</surname><given-names>I.</given-names></name>
<name><surname>Yaseen</surname><given-names>H.</given-names></name>
<name><surname>Akbar</surname><given-names>M.</given-names></name>
<name><surname>Chaudhry</surname><given-names>M.O.</given-names></name>
<name><surname>Rasool</surname><given-names>M.F.</given-names></name>
</person-group><article-title>COVID-19 Vaccine Booster Hesitancy (VBH) among Healthcare Professionals of Pakistan, a Nationwide Survey</article-title><source>Vaccines</source><year>2022</year><volume>10</volume><elocation-id>1736</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines10101736</pub-id><pub-id pub-id-type="pmid">36298600</pub-id>
</element-citation></ref><ref id="B41-vaccines-12-01411"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dale</surname><given-names>C.</given-names></name>
<name><surname>Seage</surname><given-names>C.H.</given-names></name>
<name><surname>Phillips</surname><given-names>R.</given-names></name>
<name><surname>James</surname><given-names>D.</given-names></name>
</person-group><article-title>The Role of Medication Beliefs in COVID-19 Vaccine and Booster Uptake in Healthcare Workers: An Exploratory Study</article-title><source>Healthcare</source><year>2023</year><volume>11</volume><elocation-id>1967</elocation-id><pub-id pub-id-type="doi">10.3390/healthcare11131967</pub-id><pub-id pub-id-type="pmid">37444801</pub-id>
</element-citation></ref><ref id="B42-vaccines-12-01411"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Della Polla</surname><given-names>G.</given-names></name>
<name><surname>Miraglia Del Giudice</surname><given-names>G.</given-names></name>
<name><surname>Folcarelli</surname><given-names>L.</given-names></name>
<name><surname>Napoli</surname><given-names>A.</given-names></name>
<name><surname>Angelillo</surname><given-names>I.F.</given-names></name>
</person-group><article-title>Willingness to accept a second COVID-19 vaccination booster dose among healthcare workers in Italy</article-title><source>Front. Public Health</source><year>2022</year><volume>10</volume><elocation-id>1051035</elocation-id><pub-id pub-id-type="doi">10.3389/fpubh.2022.1051035</pub-id><pub-id pub-id-type="pmid">36568799</pub-id>
</element-citation></ref><ref id="B43-vaccines-12-01411"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dudley</surname><given-names>M.Z.</given-names></name>
<name><surname>Schuh</surname><given-names>H.B.</given-names></name>
<name><surname>Forr</surname><given-names>A.</given-names></name>
<name><surname>Shaw</surname><given-names>J.</given-names></name>
<name><surname>Salmon</surname><given-names>D.A.</given-names></name>
</person-group><article-title>Changes in vaccine attitudes and recommendations among US Healthcare Personnel during the COVID-19 pandemic</article-title><source>NPJ Vaccines</source><year>2024</year><volume>9</volume><fpage>49</fpage><pub-id pub-id-type="doi">10.1038/s41541-024-00826-y</pub-id><pub-id pub-id-type="pmid">38418562</pub-id>
</element-citation></ref><ref id="B44-vaccines-12-01411"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Galanis</surname><given-names>P.</given-names></name>
<name><surname>Vraka</surname><given-names>I.</given-names></name>
<name><surname>Katsiroumpa</surname><given-names>A.</given-names></name>
<name><surname>Siskou</surname><given-names>O.</given-names></name>
<name><surname>Konstantakopoulou</surname><given-names>O.</given-names></name>
<name><surname>Katsoulas</surname><given-names>T.</given-names></name>
<name><surname>Mariolis-Sapsakos</surname><given-names>T.</given-names></name>
<name><surname>Kaitelidou</surname><given-names>D.</given-names></name>
</person-group><article-title>Predictors of second COVID-19 booster dose or new COVID-19 vaccine hesitancy among nurses: A cross-sectional study</article-title><source>J. Clin. Nurs.</source><year>2023</year><volume>32</volume><fpage>3943</fpage><lpage>3953</lpage><pub-id pub-id-type="doi">10.1111/jocn.16576</pub-id><pub-id pub-id-type="pmid">36345133</pub-id>
</element-citation></ref><ref id="B45-vaccines-12-01411"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>George</surname><given-names>G.</given-names></name>
<name><surname>Nota</surname><given-names>P.</given-names></name>
<name><surname>Strauss</surname><given-names>M.</given-names></name>
<name><surname>Lansdell</surname><given-names>E.</given-names></name>
<name><surname>Peters</surname><given-names>R.P.H.</given-names></name>
<name><surname>Brysiewicz</surname><given-names>P.</given-names></name>
<name><surname>Nadesan-Reddy</surname><given-names>N.</given-names></name>
<name><surname>Wassenaar</surname><given-names>D.</given-names></name>
</person-group><article-title>Examining the uptake of COVID-19 vaccine booster doses among healthcare workers in South Africa: A mixed-methods study</article-title><source>PLoS Glob. Public Health</source><year>2023</year><volume>3</volume><elocation-id>e0002639</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgph.0002639</pub-id><pub-id pub-id-type="pmid">37983237</pub-id>
</element-citation></ref><ref id="B46-vaccines-12-01411"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gu</surname><given-names>F.</given-names></name>
<name><surname>Lin</surname><given-names>H.</given-names></name>
<name><surname>Chen</surname><given-names>Z.</given-names></name>
<name><surname>Ambler</surname><given-names>G.</given-names></name>
<name><surname>Chen</surname><given-names>X.</given-names></name>
<name><surname>Chen</surname><given-names>X.</given-names></name>
<name><surname>Xia</surname><given-names>P.</given-names></name>
<name><surname>Liu</surname><given-names>N.</given-names></name>
<name><surname>Du</surname><given-names>H.</given-names></name>
</person-group><article-title>Future COVID-19 Booster Vaccine Refusal in Healthcare Workers after a Massive Breakthrough Infection Wave, a Nationwide Survey-Based Study</article-title><source>Vaccines</source><year>2023</year><volume>11</volume><elocation-id>987</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines11050987</pub-id><pub-id pub-id-type="pmid">37243091</pub-id>
</element-citation></ref><ref id="B47-vaccines-12-01411"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guarducci</surname><given-names>G.</given-names></name>
<name><surname>Mereu</surname><given-names>G.</given-names></name>
<name><surname>Golinelli</surname><given-names>D.</given-names></name>
<name><surname>Galletti</surname><given-names>G.</given-names></name>
<name><surname>Gemmi</surname><given-names>F.</given-names></name>
<name><surname>Cartocci</surname><given-names>A.</given-names></name>
<name><surname>Holczer</surname><given-names>N.</given-names></name>
<name><surname>Bacci</surname><given-names>L.</given-names></name>
<name><surname>Sergi</surname><given-names>A.</given-names></name>
<name><surname>Messina</surname><given-names>G.</given-names></name>
<etal/>
</person-group><article-title>Factors Influencing the Healthcare Workers&#x02019; Willingness to Receive the COVID-19 Booster Dose in Tuscany (Italy)</article-title><source>Vaccines</source><year>2023</year><volume>11</volume><elocation-id>1751</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines11121751</pub-id><pub-id pub-id-type="pmid">38140156</pub-id>
</element-citation></ref><ref id="B48-vaccines-12-01411"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krishna</surname><given-names>E.</given-names></name>
<name><surname>Karthikeyan</surname><given-names>V.</given-names></name>
<name><surname>Ahmad</surname><given-names>S.</given-names></name>
<name><surname>Ranjan</surname><given-names>A.</given-names></name>
<name><surname>Hasan Km</surname><given-names>A.</given-names></name>
<name><surname>Pandey</surname><given-names>S.</given-names></name>
<name><surname>Kumar</surname><given-names>P.</given-names></name>
<name><surname>Singh</surname><given-names>C.M.</given-names></name>
</person-group><article-title>Acceptance of Annual Booster Doses of COVID-19 Vaccines Among Indian Healthcare Professionals: A Pan-India Cross-Sectional Survey</article-title><source>Cureus</source><year>2023</year><volume>15</volume><fpage>e49363</fpage><pub-id pub-id-type="doi">10.7759/cureus.49363</pub-id><pub-id pub-id-type="pmid">38146559</pub-id>
</element-citation></ref><ref id="B49-vaccines-12-01411"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lubad</surname><given-names>M.A.</given-names></name>
<name><surname>Abu-Helalah</surname><given-names>M.A.</given-names></name>
<name><surname>Alahmad</surname><given-names>I.F.</given-names></name>
<name><surname>Al-Tamimi</surname><given-names>M.M.</given-names></name>
<name><surname>QawaQzeh</surname><given-names>M.S.</given-names></name>
<name><surname>Al-Kharabsheh</surname><given-names>A.M.</given-names></name>
<name><surname>Alzoubi</surname><given-names>H.</given-names></name>
<name><surname>Alnawafleh</surname><given-names>A.H.</given-names></name>
<name><surname>Kheirallah</surname><given-names>K.A.</given-names></name>
</person-group><article-title>Willingness of Healthcare Workers to Recommend or Receive a Third COVID-19 Vaccine Dose: A Cross-Sectional Study from Jordan</article-title><source>Infect Dis. Rep.</source><year>2023</year><volume>15</volume><fpage>210</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.3390/idr15020022</pub-id><pub-id pub-id-type="pmid">37102982</pub-id>
</element-citation></ref><ref id="B50-vaccines-12-01411"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Paudel</surname><given-names>K.</given-names></name>
<name><surname>Shah</surname><given-names>S.</given-names></name>
<name><surname>Bhusal</surname><given-names>S.</given-names></name>
<name><surname>Dahal</surname><given-names>K.</given-names></name>
<name><surname>Bhatta</surname><given-names>N.</given-names></name>
<name><surname>Pokhrel</surname><given-names>S.</given-names></name>
<name><surname>Dahal</surname><given-names>S.</given-names></name>
<name><surname>Gaihre</surname><given-names>M.</given-names></name>
<name><surname>Mudvari</surname><given-names>A.</given-names></name>
<name><surname>Gyanwali</surname><given-names>P.</given-names></name>
</person-group><article-title>Knowledge and attitude toward COVID-19 booster dose among health care professionals in Nepal: A cross-sectional study</article-title><source>Ann. Med. Surg.</source><year>2023</year><volume>85</volume><fpage>772</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1097/MS9.0000000000000434</pub-id></element-citation></ref><ref id="B51-vaccines-12-01411"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ramot</surname><given-names>S.</given-names></name>
<name><surname>Tal</surname><given-names>O.</given-names></name>
</person-group><article-title>Attitudes of Healthcare Workers in Israel towards the Fourth Dose of COVID-19 Vaccine</article-title><source>Vaccines</source><year>2023</year><volume>11</volume><elocation-id>385</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines11020385</pub-id><pub-id pub-id-type="pmid">36851263</pub-id>
</element-citation></ref><ref id="B52-vaccines-12-01411"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rathinakumar</surname><given-names>N.K.</given-names></name>
<name><surname>Nishanthi</surname><given-names>A.</given-names></name>
<name><surname>Manickam</surname><given-names>S.</given-names></name>
</person-group><article-title>Perception and practices on COVID-19 vaccination and booster dose acceptability among health-care workers&#x02014;A questionnaire-based study</article-title><source>Perspect Clin. Res.</source><year>2024</year><volume>15</volume><fpage>10</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.4103/picr.picr_64_23</pub-id><pub-id pub-id-type="pmid">38282629</pub-id>
</element-citation></ref><ref id="B53-vaccines-12-01411"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Salah</surname><given-names>H.</given-names></name>
<name><surname>Sinan</surname><given-names>I.</given-names></name>
<name><surname>Alsamani</surname><given-names>O.</given-names></name>
<name><surname>Abdelghani</surname><given-names>L.S.</given-names></name>
<name><surname>ElLithy</surname><given-names>M.H.</given-names></name>
<name><surname>Bukamal</surname><given-names>N.</given-names></name>
<name><surname>Jawad</surname><given-names>H.</given-names></name>
<name><surname>Hussein</surname><given-names>R.R.S.</given-names></name>
<name><surname>Elgendy</surname><given-names>M.O.</given-names></name>
<name><surname>Rabie</surname><given-names>A.S.I.</given-names></name>
<etal/>
</person-group><article-title>COVID-19 Booster Doses: A Multi-Center Study Reflecting Healthcare Providers&#x02019; Perceptions</article-title><source>Vaccines</source><year>2023</year><volume>11</volume><elocation-id>1061</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines11061061</pub-id><pub-id pub-id-type="pmid">37376450</pub-id>
</element-citation></ref><ref id="B54-vaccines-12-01411"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sansone</surname><given-names>V.</given-names></name>
<name><surname>Miraglia Del Giudice</surname><given-names>G.</given-names></name>
<name><surname>Della Polla</surname><given-names>G.</given-names></name>
<name><surname>Angelillo</surname><given-names>I.F.</given-names></name>
</person-group><article-title>Impact of the COVID-19 pandemic on behavioral changes in healthcare workers in Italy</article-title><source>Front. Public Health</source><year>2024</year><volume>12</volume><elocation-id>1335953</elocation-id><pub-id pub-id-type="doi">10.3389/fpubh.2024.1335953</pub-id><pub-id pub-id-type="pmid">38384871</pub-id>
</element-citation></ref><ref id="B55-vaccines-12-01411"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Viskupi&#x0010d;</surname><given-names>F.</given-names></name>
<name><surname>Wiltse</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Drivers of COVID-19 booster uptake among nurses</article-title><source>Am. J. Infect Control.</source><year>2023</year><volume>51</volume><fpage>895</fpage><lpage>899</lpage><pub-id pub-id-type="doi">10.1016/j.ajic.2022.11.014</pub-id><pub-id pub-id-type="pmid">36427700</pub-id>
</element-citation></ref><ref id="B56-vaccines-12-01411"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zoumpoulis</surname><given-names>G.</given-names></name>
<name><surname>Deligiorgi</surname><given-names>P.</given-names></name>
<name><surname>Lamprinos</surname><given-names>D.</given-names></name>
<name><surname>Georgakopoulos</surname><given-names>P.</given-names></name>
<name><surname>Oikonomou</surname><given-names>E.</given-names></name>
<name><surname>Siasos</surname><given-names>G.</given-names></name>
<name><surname>Rachiotis</surname><given-names>G.</given-names></name>
<name><surname>Damaskos</surname><given-names>C.</given-names></name>
<name><surname>Papagiannis</surname><given-names>D.</given-names></name>
<name><surname>Papavassiliou</surname><given-names>K.A.</given-names></name>
<etal/>
</person-group><article-title>Attitudes and Practices Related to COVID-19 Vaccination with the Second Booster Dose among Members of Athens Medical Association: Results from a Cross-Sectional Study</article-title><source>Vaccines</source><year>2023</year><volume>11</volume><elocation-id>1480</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines11091480</pub-id><pub-id pub-id-type="pmid">37766156</pub-id>
</element-citation></ref><ref id="B57-vaccines-12-01411"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Digregorio</surname><given-names>M.</given-names></name>
<name><surname>Van Ngoc</surname><given-names>P.</given-names></name>
<name><surname>Domen</surname><given-names>J.</given-names></name>
<name><surname>Bognar</surname><given-names>Z.</given-names></name>
<name><surname>Duysburgh</surname><given-names>E.</given-names></name>
<name><surname>Hendrickx</surname><given-names>G.</given-names></name>
<name><surname>Van Damme</surname><given-names>P.</given-names></name>
<name><surname>Coenen</surname><given-names>S.</given-names></name>
<name><surname>Scholtes</surname><given-names>B.</given-names></name>
</person-group><article-title>Primary Healthcare Providers&#x02019; Views on Periodic COVID-19 Booster Vaccination for Themselves and Their Patients: A 2023 Nationwide Survey in Belgium</article-title><source>Vaccines</source><year>2024</year><volume>12</volume><elocation-id>740</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines12070740</pub-id><pub-id pub-id-type="pmid">39066378</pub-id>
</element-citation></ref><ref id="B58-vaccines-12-01411"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kolomba</surname><given-names>B.M.</given-names></name>
<name><surname>Kalenga Luhembwe</surname><given-names>F.</given-names></name>
<name><surname>Ndala</surname><given-names>D.B.B.</given-names></name>
<name><surname>Kanku Wa Ilunga</surname><given-names>P.</given-names></name>
<name><surname>Ciamala Mukendi</surname><given-names>P.</given-names></name>
<name><surname>Ngongo Kitenge</surname><given-names>A.</given-names></name>
<name><surname>Ngoy Lumbule</surname><given-names>J.</given-names></name>
<name><surname>Kilolo Ngoy</surname><given-names>E.</given-names></name>
<name><surname>Umba Ilunga</surname><given-names>A.</given-names></name>
<name><surname>Mbidi Miema</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Healthcare workers&#x02019; willingness to receive COVID-19 booster dose and associated factors in the Democratic Republic of the Congo</article-title><source>Hum. Vaccin. Immunother.</source><year>2024</year><volume>20</volume><fpage>2357214</fpage><pub-id pub-id-type="doi">10.1080/21645515.2024.2357214</pub-id><pub-id pub-id-type="pmid">38783665</pub-id>
</element-citation></ref><ref id="B59-vaccines-12-01411"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pandarathodiyil</surname><given-names>A.K.</given-names></name>
<name><surname>Veerabhadrappa</surname><given-names>S.K.</given-names></name>
<name><surname>Nabillah Ghani</surname><given-names>W.M.</given-names></name>
<name><surname>Termizi Bin Zamzuri</surname><given-names>A.</given-names></name>
</person-group><article-title>COVID-19 Booster Vaccination Adverse Effects and Willingness to Receive a Yearly Booster Dose among Members of Health Sciences Faculties: A Descriptive Cross-Sectional Study</article-title><source>J. Pharm. Bioallied. Sci.</source><year>2024</year><volume>16</volume><fpage>S1776</fpage><lpage>S1783</lpage><pub-id pub-id-type="doi">10.4103/jpbs.jpbs_1149_23</pub-id><pub-id pub-id-type="pmid">38882761</pub-id>
</element-citation></ref><ref id="B60-vaccines-12-01411"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pristov</surname><given-names>Z.</given-names></name>
<name><surname>Lobe</surname><given-names>B.</given-names></name>
<name><surname>So&#x0010d;an</surname><given-names>M.</given-names></name>
</person-group><article-title>Factors Influencing COVID-19 Vaccination among Primary Healthcare Nurses in the Pandemic and Post-Pandemic Period: Cross-Sectional Study</article-title><source>Vaccines</source><year>2024</year><volume>12</volume><elocation-id>602</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines12060602</pub-id><pub-id pub-id-type="pmid">38932331</pub-id>
</element-citation></ref><ref id="B61-vaccines-12-01411"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Roberts</surname><given-names>S.C.</given-names></name>
<name><surname>Willebrand</surname><given-names>K.</given-names></name>
<name><surname>Fredrick</surname><given-names>J.</given-names></name>
<name><surname>Pischel</surname><given-names>L.</given-names></name>
<name><surname>Patel</surname><given-names>K.</given-names></name>
<name><surname>Murray</surname><given-names>T.S.</given-names></name>
<name><surname>Martinello</surname><given-names>R.A.</given-names></name>
</person-group><article-title>Characterizing healthcare personnel attitudes toward receipt of a voluntary bivalent COVID-19 booster vaccine during a COVID-19 outbreak at a behavioral health hospital in Connecticut</article-title><source>Antimicrob. Steward. Healthc. Epidemiol.</source><year>2024</year><volume>4</volume><fpage>e87</fpage><pub-id pub-id-type="doi">10.1017/ash.2024.78</pub-id><pub-id pub-id-type="pmid">38774120</pub-id>
</element-citation></ref><ref id="B62-vaccines-12-01411"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Russ</surname><given-names>S.</given-names></name>
<name><surname>Myers</surname><given-names>C.</given-names></name>
<name><surname>Licherdell</surname><given-names>E.</given-names></name>
<name><surname>Bowden</surname><given-names>A.</given-names></name>
<name><surname>Chinchilli</surname><given-names>E.</given-names></name>
<name><surname>Dahhan</surname><given-names>R.</given-names></name>
<name><surname>Van Wijngaarden</surname><given-names>E.</given-names></name>
<name><surname>Plumb</surname><given-names>I.D.</given-names></name>
<name><surname>Dumyati</surname><given-names>G.</given-names></name>
</person-group><article-title>Sociodemographic and Occupational Characteristics Associated with Early and Continued COVID-19 Vaccine Uptake Among Healthcare Personnel: Monroe County, NY</article-title><source>Vaccine</source><year>2024</year><volume>42</volume><fpage>2585</fpage><lpage>2591</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2024.03.019</pub-id><pub-id pub-id-type="pmid">38480100</pub-id>
</element-citation></ref><ref id="B63-vaccines-12-01411"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Baghani</surname><given-names>M.</given-names></name>
<name><surname>Fathalizade</surname><given-names>F.</given-names></name>
<name><surname>Loghman</surname><given-names>A.H.</given-names></name>
<name><surname>Samieefar</surname><given-names>N.</given-names></name>
<name><surname>Ghobadinezhad</surname><given-names>F.</given-names></name>
<name><surname>Rashedi</surname><given-names>R.</given-names></name>
<name><surname>Baghsheikhi</surname><given-names>H.</given-names></name>
<name><surname>Sodeifian</surname><given-names>F.</given-names></name>
<name><surname>Rahimzadegan</surname><given-names>M.</given-names></name>
<name><surname>Akhlaghdoust</surname><given-names>M.</given-names></name>
</person-group><article-title>COVID-19 vaccine hesitancy worldwide and its associated factors: A systematic review and meta-analysis</article-title><source>Sci. One Health</source><year>2023</year><volume>2</volume><fpage>100048</fpage><pub-id pub-id-type="doi">10.1016/j.soh.2023.100048</pub-id><pub-id pub-id-type="pmid">39077035</pub-id>
</element-citation></ref><ref id="B64-vaccines-12-01411"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dror</surname><given-names>A.A.</given-names></name>
<name><surname>Eisenbach</surname><given-names>N.</given-names></name>
<name><surname>Taiber</surname><given-names>S.</given-names></name>
<name><surname>Morozov</surname><given-names>N.G.</given-names></name>
<name><surname>Mizrachi</surname><given-names>M.</given-names></name>
<name><surname>Zigron</surname><given-names>A.</given-names></name>
<name><surname>Srouji</surname><given-names>S.</given-names></name>
<name><surname>Sela</surname><given-names>E.</given-names></name>
</person-group><article-title>Vaccine hesitancy: The next challenge in the fight against COVID-19</article-title><source>Eur. J. Epidemiol.</source><year>2020</year><volume>35</volume><fpage>775</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1007/s10654-020-00671-y</pub-id><pub-id pub-id-type="pmid">32785815</pub-id>
</element-citation></ref><ref id="B65-vaccines-12-01411"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barello</surname><given-names>S.</given-names></name>
<name><surname>Nania</surname><given-names>T.</given-names></name>
<name><surname>Dellafiore</surname><given-names>F.</given-names></name>
<name><surname>Graffigna</surname><given-names>G.</given-names></name>
<name><surname>Caruso</surname><given-names>R.</given-names></name>
</person-group><article-title>&#x02018;Vaccine hesitancy&#x02019; among university students in Italy during the COVID-19 pandemic</article-title><source>Eur. J. Epidemiol.</source><year>2020</year><volume>35</volume><fpage>781</fpage><lpage>783</lpage><pub-id pub-id-type="doi">10.1007/s10654-020-00670-z</pub-id><pub-id pub-id-type="pmid">32761440</pub-id>
</element-citation></ref><ref id="B66-vaccines-12-01411"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kaur</surname><given-names>M.</given-names></name>
<name><surname>Coppeta</surname><given-names>L.</given-names></name>
<name><surname>Olesen</surname><given-names>O.F.</given-names></name>
</person-group><article-title>Vaccine Hesitancy among Healthcare Workers in Europe: A Systematic Review</article-title><source>Vaccines</source><year>2023</year><volume>11</volume><elocation-id>1657</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines11111657</pub-id><pub-id pub-id-type="pmid">38005989</pub-id>
</element-citation></ref><ref id="B67-vaccines-12-01411"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dudley</surname><given-names>M.Z.</given-names></name>
<name><surname>Halsey</surname><given-names>N.A.</given-names></name>
<name><surname>Omer</surname><given-names>S.B.</given-names></name>
<name><surname>Orenstein</surname><given-names>W.A.</given-names></name>
<name><surname>T O&#x02019;Leary</surname><given-names>S.</given-names></name>
<name><surname>Limaye</surname><given-names>R.J.</given-names></name>
<name><surname>Salmon</surname><given-names>D.A.</given-names></name>
</person-group><article-title>The state of vaccine safety science: Systematic reviews of the evidence</article-title><source>Lancet Infect. Dis.</source><year>2020</year><volume>20</volume><fpage>e80</fpage><lpage>e89</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30130-4</pub-id><pub-id pub-id-type="pmid">32278359</pub-id>
</element-citation></ref><ref id="B68-vaccines-12-01411"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lip</surname><given-names>A.</given-names></name>
<name><surname>Pateman</surname><given-names>M.</given-names></name>
<name><surname>Fullerton</surname><given-names>M.M.</given-names></name>
<name><surname>Chen</surname><given-names>H.M.</given-names></name>
<name><surname>Bailey</surname><given-names>L.</given-names></name>
<name><surname>Houle</surname><given-names>S.</given-names></name>
<name><surname>Davidson</surname><given-names>S.</given-names></name>
<name><surname>Constantinescu</surname><given-names>C.</given-names></name>
</person-group><article-title>Vaccine hesitancy educational tools for healthcare providers and trainees: A scoping review</article-title><source>Vaccine</source><year>2023</year><volume>41</volume><fpage>23</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2022.09.093</pub-id><pub-id pub-id-type="pmid">36437208</pub-id>
</element-citation></ref><ref id="B69-vaccines-12-01411"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Suliman</surname><given-names>D.M.</given-names></name>
<name><surname>Nawaz</surname><given-names>F.A.</given-names></name>
<name><surname>Mohanan</surname><given-names>P.</given-names></name>
<name><surname>Modber</surname><given-names>M.</given-names></name>
<name><surname>Musa</surname><given-names>M.K.</given-names></name>
<name><surname>Musa</surname><given-names>M.B.</given-names></name>
<name><surname>El Chbib</surname><given-names>D.</given-names></name>
<name><surname>Elhadi</surname><given-names>Y.A.M.</given-names></name>
<name><surname>Essar</surname><given-names>M.Y.</given-names></name>
<name><surname>Isa</surname><given-names>M.A.</given-names></name>
<etal/>
</person-group><article-title>UAE efforts in promoting COVID-19 vaccination and building vaccine confidence</article-title><source>Vaccine</source><year>2021</year><volume>39</volume><fpage>6341</fpage><lpage>6345</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2021.09.015</pub-id><pub-id pub-id-type="pmid">34561138</pub-id>
</element-citation></ref><ref id="B70-vaccines-12-01411"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bianchi</surname><given-names>F.P.</given-names></name>
<name><surname>Stefanizzi</surname><given-names>P.</given-names></name>
<name><surname>Brescia</surname><given-names>N.</given-names></name>
<name><surname>Lattanzio</surname><given-names>S.</given-names></name>
<name><surname>Martinelli</surname><given-names>A.</given-names></name>
<name><surname>Tafuri</surname><given-names>S.</given-names></name>
</person-group><article-title>COVID-19 vaccination hesitancy in Italian healthcare workers: A systematic review and meta-analysis</article-title><source>Expert Rev. Vaccines</source><year>2022</year><volume>21</volume><fpage>1289</fpage><lpage>1300</lpage><pub-id pub-id-type="doi">10.1080/14760584.2022.2093723</pub-id><pub-id pub-id-type="pmid">35757890</pub-id>
</element-citation></ref><ref id="B71-vaccines-12-01411"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hall</surname><given-names>C.M.</given-names></name>
<name><surname>Northam</surname><given-names>H.</given-names></name>
<name><surname>Webster</surname><given-names>A.</given-names></name>
<name><surname>Strickland</surname><given-names>K.</given-names></name>
</person-group><article-title>Determinants of seasonal influenza vaccination hesitancy among healthcare personnel: An integrative review</article-title><source>J. Clin. Nurs.</source><year>2022</year><volume>31</volume><fpage>2112</fpage><lpage>2124</lpage><pub-id pub-id-type="doi">10.1111/jocn.16103</pub-id><pub-id pub-id-type="pmid">34716635</pub-id>
</element-citation></ref><ref id="B72-vaccines-12-01411"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alalawi</surname><given-names>M.</given-names></name>
<name><surname>Alsalloum</surname><given-names>M.A.</given-names></name>
<name><surname>Garwan</surname><given-names>Y.M.</given-names></name>
<name><surname>Abuzeid</surname><given-names>M.</given-names></name>
<name><surname>Alalawi</surname><given-names>H.</given-names></name>
<name><surname>Eljaaly</surname><given-names>K.</given-names></name>
<name><surname>Thabit</surname><given-names>A.K.</given-names></name>
<name><surname>Jose</surname><given-names>J.</given-names></name>
</person-group><article-title>COVID-19 vaccine hesitancy among healthcare workers in Arab Countries: A systematic review and meta-analysis</article-title><source>PLoS ONE</source><year>2024</year><volume>19</volume><elocation-id>e0296432</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0296432</pub-id><pub-id pub-id-type="pmid">38166119</pub-id>
</element-citation></ref><ref id="B73-vaccines-12-01411"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mollalo</surname><given-names>A.</given-names></name>
<name><surname>Tatar</surname><given-names>M.</given-names></name>
</person-group><article-title>Spatial Modeling of COVID-19 Vaccine Hesitancy in the United States</article-title><source>Int. J. Environ. Res. Public Health</source><year>2021</year><volume>18</volume><elocation-id>9488</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph18189488</pub-id><pub-id pub-id-type="pmid">34574416</pub-id>
</element-citation></ref><ref id="B74-vaccines-12-01411"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moradpour</surname><given-names>J.</given-names></name>
<name><surname>Shajarizadeh</surname><given-names>A.</given-names></name>
<name><surname>Carter</surname><given-names>J.</given-names></name>
<name><surname>Chit</surname><given-names>A.</given-names></name>
<name><surname>Grootendorst</surname><given-names>P.</given-names></name>
</person-group><article-title>The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptake</article-title><source>PLoS ONE</source><year>2023</year><volume>18</volume><elocation-id>e0293184</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0293184</pub-id><pub-id pub-id-type="pmid">37917650</pub-id>
</element-citation></ref><ref id="B75-vaccines-12-01411"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schaefer</surname><given-names>G.O.</given-names></name>
<name><surname>Leland</surname><given-names>R.</given-names></name>
<name><surname>Emanuel</surname><given-names>E.J.</given-names></name>
</person-group><article-title>Making vaccines available to other countries before offering domestic booster vaccinations</article-title><source>JAMA</source><year>2021</year><volume>326</volume><fpage>903</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1001/jama.2021.13226</pub-id><pub-id pub-id-type="pmid">34382999</pub-id>
</element-citation></ref><ref id="B76-vaccines-12-01411"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Diseases</surname><given-names>T.L.I.</given-names></name>
</person-group><article-title>COVID-19 vaccine equity and booster doses</article-title><source>Lancet. Infect. Dis.</source><year>2021</year><volume>21</volume><fpage>1193</fpage><pub-id pub-id-type="doi">10.1016/S1473-3099(21)00486-2</pub-id><pub-id pub-id-type="pmid">34391506</pub-id>
</element-citation></ref><ref id="B77-vaccines-12-01411"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tselebis</surname><given-names>A.</given-names></name>
<name><surname>Sikaras</surname><given-names>C.</given-names></name>
<name><surname>Milionis</surname><given-names>C.</given-names></name>
<name><surname>Sideri</surname><given-names>E.P.</given-names></name>
<name><surname>Fytsilis</surname><given-names>K.</given-names></name>
<name><surname>Papageorgiou</surname><given-names>S.M.</given-names></name>
<name><surname>Ilias</surname><given-names>I.</given-names></name>
<name><surname>Pachi</surname><given-names>A.</given-names></name>
</person-group><article-title>A Moderated Mediation Model of the Influence of Cynical Distrust, Medical Mistrust, and Anger on Vaccination Hesitancy in Nursing Staff</article-title><source>Eur. J. Investig. Health Psychol. Educ.</source><year>2023</year><volume>13</volume><fpage>2373</fpage><lpage>2387</lpage><pub-id pub-id-type="doi">10.3390/ejihpe13110167</pub-id></element-citation></ref><ref id="B78-vaccines-12-01411"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Galanis</surname><given-names>P.</given-names></name>
<name><surname>Moisoglou</surname><given-names>I.</given-names></name>
<name><surname>Vraka</surname><given-names>I.</given-names></name>
<name><surname>Siskou</surname><given-names>O.</given-names></name>
<name><surname>Konstantakopoulou</surname><given-names>O.</given-names></name>
<name><surname>Katsiroumpa</surname><given-names>A.</given-names></name>
<name><surname>Kaitelidou</surname><given-names>D.</given-names></name>
</person-group><article-title>Predictors of COVID-19 vaccine uptake in healthcare workers: A cross-sectional study in Greece</article-title><source>J. Occup. Environ. Med.</source><year>2022</year><volume>64</volume><fpage>e191</fpage><lpage>e196</lpage><pub-id pub-id-type="doi">10.1097/JOM.0000000000002463</pub-id><pub-id pub-id-type="pmid">35467601</pub-id>
</element-citation></ref><ref id="B79-vaccines-12-01411"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bell</surname><given-names>S.</given-names></name>
<name><surname>Clarke</surname><given-names>R.M.</given-names></name>
<name><surname>Ismail</surname><given-names>S.A.</given-names></name>
<name><surname>Ojo-Aromokudu</surname><given-names>O.</given-names></name>
<name><surname>Naqvi</surname><given-names>H.</given-names></name>
<name><surname>Coghill</surname><given-names>Y.</given-names></name>
<name><surname>Donovan</surname><given-names>H.</given-names></name>
<name><surname>Letley</surname><given-names>L.</given-names></name>
<name><surname>Paterson</surname><given-names>P.</given-names></name>
<name><surname>Mounier-Jack</surname><given-names>S.</given-names></name>
</person-group><article-title>COVID-19 vaccination beliefs, attitudes, and behaviours among health and social care workers in the UK: A mixed-methods study</article-title><source>PLoS ONE</source><year>2022</year><volume>17</volume><elocation-id>e0260949</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0260949</pub-id><pub-id pub-id-type="pmid">35073312</pub-id>
</element-citation></ref><ref id="B80-vaccines-12-01411"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kigongo</surname><given-names>E.</given-names></name>
<name><surname>Kabunga</surname><given-names>A.</given-names></name>
<name><surname>Tumwesigye</surname><given-names>R.</given-names></name>
<name><surname>Musinguzi</surname><given-names>M.</given-names></name>
<name><surname>Izaruku</surname><given-names>R.</given-names></name>
<name><surname>Acup</surname><given-names>W.</given-names></name>
</person-group><article-title>Prevalence and predictors of COVID-19 vaccination hesitancy among healthcare workers in Sub-Saharan Africa: A systematic review and meta-analysis</article-title><source>PLoS ONE</source><year>2023</year><volume>18</volume><elocation-id>e0289295</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0289295</pub-id><pub-id pub-id-type="pmid">37506132</pub-id>
</element-citation></ref><ref id="B81-vaccines-12-01411"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
</person-group><article-title>Multilevel determinants of COVID-19 vaccination hesitancy in the United States: A rapid systematic review</article-title><source>Prev. Med. Rep.</source><year>2022</year><volume>25</volume><fpage>101673</fpage><pub-id pub-id-type="doi">10.1016/j.pmedr.2021.101673</pub-id><pub-id pub-id-type="pmid">34934611</pub-id>
</element-citation></ref><ref id="B82-vaccines-12-01411"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bianchi</surname><given-names>F.P.</given-names></name>
<name><surname>Stefanizzi</surname><given-names>P.</given-names></name>
<name><surname>Cuscianna</surname><given-names>E.</given-names></name>
<name><surname>Riformato</surname><given-names>G.</given-names></name>
<name><surname>Di Lorenzo</surname><given-names>A.</given-names></name>
<name><surname>Giordano</surname><given-names>P.</given-names></name>
<name><surname>Germinario</surname><given-names>C.A.</given-names></name>
<name><surname>Tafuri</surname><given-names>S.</given-names></name>
</person-group><article-title>COVID-19 vaccination hesitancy among Italian parents: A systematic review and meta-analysis</article-title><source>Hum. Vaccin. Immunother.</source><year>2023</year><volume>19</volume><fpage>2171185</fpage><pub-id pub-id-type="doi">10.1080/21645515.2023.2171185</pub-id><pub-id pub-id-type="pmid">36698309</pub-id>
</element-citation></ref><ref id="B83-vaccines-12-01411"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Issaris</surname><given-names>V.</given-names></name>
<name><surname>Kalogerakos</surname><given-names>G.</given-names></name>
<name><surname>Milas</surname><given-names>G.P.</given-names></name>
</person-group><article-title>Vaccination Hesitancy Among Greek Orthodox Christians: Is There a Conflict Between Religion and Science?</article-title><source>J. Relig. Health</source><year>2023</year><volume>62</volume><fpage>1373</fpage><lpage>1378</lpage><pub-id pub-id-type="doi">10.1007/s10943-023-01759-x</pub-id><pub-id pub-id-type="pmid">36757641</pub-id>
</element-citation></ref><ref id="B84-vaccines-12-01411"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Irrgang</surname><given-names>P.</given-names></name>
<name><surname>Gerling</surname><given-names>J.</given-names></name>
<name><surname>Kocher</surname><given-names>K.</given-names></name>
<name><surname>Lapuente</surname><given-names>D.</given-names></name>
<name><surname>Steininger</surname><given-names>P.</given-names></name>
<name><surname>Habenicht</surname><given-names>K.</given-names></name>
<name><surname>Wytopil</surname><given-names>M.</given-names></name>
<name><surname>Beileke</surname><given-names>S.</given-names></name>
<name><surname>Sch&#x000e4;fer</surname><given-names>S.</given-names></name>
<name><surname>Zhong</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination</article-title><source>Sci. Immunol.</source><year>2023</year><volume>8</volume><fpage>eade2798</fpage><pub-id pub-id-type="doi">10.1126/sciimmunol.ade2798</pub-id><pub-id pub-id-type="pmid">36548397</pub-id>
</element-citation></ref><ref id="B85-vaccines-12-01411"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Uversky</surname><given-names>V.N.</given-names></name>
<name><surname>Redwan</surname><given-names>E.M.</given-names></name>
<name><surname>Makis</surname><given-names>W.</given-names></name>
<name><surname>Rubio-Casillas</surname><given-names>A.</given-names></name>
</person-group><article-title>IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein</article-title><source>Vaccines</source><year>2023</year><volume>11</volume><elocation-id>991</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines11050991</pub-id><pub-id pub-id-type="pmid">37243095</pub-id>
</element-citation></ref><ref id="B86-vaccines-12-01411"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stowe</surname><given-names>J.</given-names></name>
<name><surname>Miller</surname><given-names>E.</given-names></name>
<name><surname>Andrews</surname><given-names>N.</given-names></name>
<name><surname>Whitaker</surname><given-names>H.J.</given-names></name>
</person-group><article-title>Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England</article-title><source>PLoS Med.</source><year>2023</year><volume>20</volume><elocation-id>e1004245</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1004245</pub-id><pub-id pub-id-type="pmid">37285378</pub-id>
</element-citation></ref><ref id="B87-vaccines-12-01411"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abraham</surname><given-names>N.</given-names></name>
<name><surname>Spruin</surname><given-names>S.</given-names></name>
<name><surname>Rossi</surname><given-names>T.</given-names></name>
<name><surname>Fireman</surname><given-names>B.</given-names></name>
<name><surname>Zafack</surname><given-names>J.</given-names></name>
<name><surname>Blaser</surname><given-names>C.</given-names></name>
<name><surname>Shaw</surname><given-names>A.</given-names></name>
<name><surname>Hutchings</surname><given-names>K.</given-names></name>
<name><surname>Ogunnaike-Cooke</surname><given-names>S.</given-names></name>
</person-group><article-title>Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines</article-title><source>Vaccine</source><year>2022</year><volume>40</volume><fpage>4663</fpage><lpage>4671</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2022.05.048</pub-id><pub-id pub-id-type="pmid">35750537</pub-id>
</element-citation></ref><ref id="B88-vaccines-12-01411"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jain</surname><given-names>N.</given-names></name>
<name><surname>Chaudhary</surname><given-names>P.</given-names></name>
<name><surname>Shrivastava</surname><given-names>A.</given-names></name>
<name><surname>Kaur</surname><given-names>T.</given-names></name>
<name><surname>Kaur</surname><given-names>S.</given-names></name>
<name><surname>Brar</surname><given-names>H.S.</given-names></name>
<name><surname>Jindal</surname><given-names>R.</given-names></name>
</person-group><article-title>Thrombosis with Thrombocytopenia Syndrome (TTS) After ChAdOx1 nCoV-19 Immunization: An Investigative Case Report</article-title><source>Am. J. Case Rep.</source><year>2023</year><volume>24</volume><fpage>e938878</fpage><pub-id pub-id-type="doi">10.12659/AJCR.938878</pub-id><pub-id pub-id-type="pmid">36932639</pub-id>
</element-citation></ref><ref id="B89-vaccines-12-01411"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Islam</surname><given-names>A.</given-names></name>
<name><surname>Bashir</surname><given-names>M.S.</given-names></name>
<name><surname>Joyce</surname><given-names>K.</given-names></name>
<name><surname>Rashid</surname><given-names>H.</given-names></name>
<name><surname>Laher</surname><given-names>I.</given-names></name>
<name><surname>Elshazly</surname><given-names>S.</given-names></name>
</person-group><article-title>An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management Recommendations</article-title><source>Molecules</source><year>2021</year><volume>26</volume><elocation-id>5004</elocation-id><pub-id pub-id-type="doi">10.3390/molecules26165004</pub-id><pub-id pub-id-type="pmid">34443589</pub-id>
</element-citation></ref><ref id="B90-vaccines-12-01411"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tran</surname><given-names>H.A.</given-names></name>
<name><surname>Deng</surname><given-names>L.</given-names></name>
<name><surname>Wood</surname><given-names>N.</given-names></name>
<name><surname>Choi</surname><given-names>P.</given-names></name>
<name><surname>Singleton</surname><given-names>S.</given-names></name>
<name><surname>Clarke</surname><given-names>L.</given-names></name>
<name><surname>Khanlari</surname><given-names>S.</given-names></name>
<name><surname>Maitland-Scott</surname><given-names>I.</given-names></name>
<name><surname>Bird</surname><given-names>R.</given-names></name>
<name><surname>Brown</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: A population-based study</article-title><source>Lancet Reg. Health West. Pac.</source><year>2023</year><volume>40</volume><fpage>100894</fpage><pub-id pub-id-type="doi">10.1016/j.lanwpc.2023.100894</pub-id><pub-id pub-id-type="pmid">37701717</pub-id>
</element-citation></ref><ref id="B91-vaccines-12-01411"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lang</surname><given-names>A.L.</given-names></name>
<name><surname>Hohmuth</surname><given-names>N.</given-names></name>
<name><surname>Vi&#x00161;kovi&#x00107;</surname><given-names>V.</given-names></name>
<name><surname>Konigorski</surname><given-names>S.</given-names></name>
<name><surname>Scholz</surname><given-names>S.</given-names></name>
<name><surname>Balzer</surname><given-names>F.</given-names></name>
<name><surname>Remschmidt</surname><given-names>C.</given-names></name>
<name><surname>Leistner</surname><given-names>R.</given-names></name>
</person-group><article-title>COVID-19 Vaccine Effectiveness and Digital Pandemic Surveillance in Germany (eCOV Study): Web Application-Based Prospective Observational Cohort Study</article-title><source>J. Med. Internet. Res.</source><year>2024</year><volume>26</volume><fpage>e47070</fpage><pub-id pub-id-type="doi">10.2196/47070</pub-id><pub-id pub-id-type="pmid">38833299</pub-id>
</element-citation></ref><ref id="B92-vaccines-12-01411"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gram</surname><given-names>M.A.</given-names></name>
<name><surname>Emborg</surname><given-names>H.D.</given-names></name>
<name><surname>Schelde</surname><given-names>A.B.</given-names></name>
<name><surname>Friis</surname><given-names>N.U.</given-names></name>
<name><surname>Nielsen</surname><given-names>K.F.</given-names></name>
<name><surname>Moustsen-Helms</surname><given-names>I.R.</given-names></name>
<name><surname>Legarth</surname><given-names>R.</given-names></name>
<name><surname>Lam</surname><given-names>J.U.H.</given-names></name>
<name><surname>Chaine</surname><given-names>M.</given-names></name>
<name><surname>Malik</surname><given-names>A.Z.</given-names></name>
<etal/>
</person-group><article-title>Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study</article-title><source>PLoS Med.</source><year>2022</year><volume>19</volume><elocation-id>e1003992</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1003992</pub-id><pub-id pub-id-type="pmid">36048766</pub-id>
</element-citation></ref><ref id="B93-vaccines-12-01411"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garrett</surname><given-names>M.E.</given-names></name>
<name><surname>Galloway</surname><given-names>J.G.</given-names></name>
<name><surname>Wolf</surname><given-names>C.</given-names></name>
<name><surname>Logue</surname><given-names>J.K.</given-names></name>
<name><surname>Franko</surname><given-names>N.</given-names></name>
<name><surname>Chu</surname><given-names>H.Y.</given-names></name>
<name><surname>Matsen</surname><given-names>F.A.t.</given-names></name>
<name><surname>Overbaugh</surname><given-names>J.M.</given-names></name>
</person-group><article-title>Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection</article-title><source>Elife</source><year>2022</year><volume>11</volume><fpage>e73490</fpage><pub-id pub-id-type="doi">10.7554/eLife.73490</pub-id><pub-id pub-id-type="pmid">35072628</pub-id>
</element-citation></ref><ref id="B94-vaccines-12-01411"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Katz</surname><given-names>M.A.</given-names></name>
<name><surname>Rojas Castro</surname><given-names>M.Y.</given-names></name>
<name><surname>Chakhunashvili</surname><given-names>G.</given-names></name>
<name><surname>Chitadze</surname><given-names>N.</given-names></name>
<name><surname>Ward</surname><given-names>C.L.</given-names></name>
<name><surname>McKnight</surname><given-names>C.J.</given-names></name>
<name><surname>Lucaccioni</surname><given-names>H.</given-names></name>
<name><surname>Finci</surname><given-names>I.</given-names></name>
<name><surname>Zardiashvili</surname><given-names>T.</given-names></name>
<name><surname>Pebody</surname><given-names>R.</given-names></name>
<etal/>
</person-group><article-title>Primary series COVID-19 vaccine effectiveness among health care workers in the country of Georgia, March&#x02013;December 2021</article-title><source>PLoS ONE</source><year>2024</year><volume>19</volume><elocation-id>e0307805</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0307805</pub-id><pub-id pub-id-type="pmid">39240827</pub-id>
</element-citation></ref><ref id="B95-vaccines-12-01411"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Haas</surname><given-names>E.J.</given-names></name>
<name><surname>Angulo</surname><given-names>F.J.</given-names></name>
<name><surname>McLaughlin</surname><given-names>J.M.</given-names></name>
<name><surname>Anis</surname><given-names>E.</given-names></name>
<name><surname>Singer</surname><given-names>S.R.</given-names></name>
<name><surname>Khan</surname><given-names>F.</given-names></name>
<name><surname>Brooks</surname><given-names>N.</given-names></name>
<name><surname>Smaja</surname><given-names>M.</given-names></name>
<name><surname>Mircus</surname><given-names>G.</given-names></name>
<name><surname>Pan</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: An observational study using national surveillance data</article-title><source>Lancet</source><year>2021</year><volume>397</volume><fpage>1819</fpage><lpage>1829</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)00947-8</pub-id><pub-id pub-id-type="pmid">33964222</pub-id>
</element-citation></ref><ref id="B96-vaccines-12-01411"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Haque</surname><given-names>A.</given-names></name>
<name><surname>Pant</surname><given-names>A.B.</given-names></name>
</person-group><article-title>Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy</article-title><source>J. Autoimmun.</source><year>2022</year><volume>127</volume><fpage>102792</fpage><pub-id pub-id-type="doi">10.1016/j.jaut.2021.102792</pub-id><pub-id pub-id-type="pmid">34995958</pub-id>
</element-citation></ref><ref id="B97-vaccines-12-01411"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gra&#x000f1;a</surname><given-names>C.</given-names></name>
<name><surname>Ghosn</surname><given-names>L.</given-names></name>
<name><surname>Evrenoglou</surname><given-names>T.</given-names></name>
<name><surname>Jarde</surname><given-names>A.</given-names></name>
<name><surname>Minozzi</surname><given-names>S.</given-names></name>
<name><surname>Bergman</surname><given-names>H.</given-names></name>
<name><surname>Buckley</surname><given-names>B.S.</given-names></name>
<name><surname>Probyn</surname><given-names>K.</given-names></name>
<name><surname>Villanueva</surname><given-names>G.</given-names></name>
<name><surname>Henschke</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>Efficacy and safety of COVID-19 vaccines</article-title><source>Cochrane Database Syst. Rev.</source><year>2022</year><volume>12</volume><fpage>Cd015477</fpage><pub-id pub-id-type="doi">10.1002/14651858.Cd015477</pub-id><pub-id pub-id-type="pmid">36473651</pub-id>
</element-citation></ref><ref id="B98-vaccines-12-01411"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Waele</surname><given-names>A.</given-names></name>
<name><surname>Hendrickx</surname><given-names>G.</given-names></name>
<name><surname>Valckx</surname><given-names>S.</given-names></name>
<name><surname>Dom&#x000ed;nguez</surname><given-names>&#x000c0;.</given-names></name>
<name><surname>Toledo</surname><given-names>D.</given-names></name>
<name><surname>Castilla</surname><given-names>J.</given-names></name>
<name><surname>Tuells</surname><given-names>J.</given-names></name>
<name><surname>Van Damme</surname><given-names>P.</given-names></name>
</person-group><article-title>The Vaccine Training Barometer: Assessing healthcare providers&#x02019; confidence to answer vaccine-related questions and their training needs</article-title><source>Vaccine</source><year>2024</year><volume>42</volume><fpage>2421</fpage><lpage>2428</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2024.02.078</pub-id><pub-id pub-id-type="pmid">38458873</pub-id>
</element-citation></ref><ref id="B99-vaccines-12-01411"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Paterson</surname><given-names>P.</given-names></name>
<name><surname>Meurice</surname><given-names>F.</given-names></name>
<name><surname>Stanberry</surname><given-names>L.R.</given-names></name>
<name><surname>Glismann</surname><given-names>S.</given-names></name>
<name><surname>Rosenthal</surname><given-names>S.L.</given-names></name>
<name><surname>Larson</surname><given-names>H.J.</given-names></name>
</person-group><article-title>Vaccine hesitancy and healthcare providers</article-title><source>Vaccine</source><year>2016</year><volume>34</volume><fpage>6700</fpage><lpage>6706</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2016.10.042</pub-id><pub-id pub-id-type="pmid">27810314</pub-id>
</element-citation></ref><ref id="B100-vaccines-12-01411"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moghnieh</surname><given-names>R.</given-names></name>
<name><surname>Haddad</surname><given-names>W.</given-names></name>
<name><surname>Jbeily</surname><given-names>N.</given-names></name>
<name><surname>El-Hassan</surname><given-names>S.</given-names></name>
<name><surname>Eid</surname><given-names>S.</given-names></name>
<name><surname>Baba</surname><given-names>H.</given-names></name>
<name><surname>Sily</surname><given-names>M.</given-names></name>
<name><surname>Saber</surname><given-names>Y.</given-names></name>
<name><surname>Abdallah</surname><given-names>D.</given-names></name>
<name><surname>Bizri</surname><given-names>A.R.</given-names></name>
<etal/>
</person-group><article-title>Immunogenicity and real-world effectiveness of COVID-19 vaccines in Lebanon: Insights from primary and booster schemes, variants, infections, and hospitalization</article-title><source>PLoS ONE</source><year>2024</year><volume>19</volume><elocation-id>e0306457</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0306457</pub-id><pub-id pub-id-type="pmid">39269963</pub-id>
</element-citation></ref><ref id="B101-vaccines-12-01411"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barosa</surname><given-names>M.</given-names></name>
<name><surname>Ioannidis</surname><given-names>J.P.A.</given-names></name>
<name><surname>Prasad</surname><given-names>V.</given-names></name>
</person-group><article-title>Evidence base for yearly respiratory virus vaccines: Current status and proposed improved strategies</article-title><source>Eur. J. Clin. Investig.</source><year>2024</year><volume>54</volume><fpage>e14286</fpage><pub-id pub-id-type="doi">10.1111/eci.14286</pub-id><pub-id pub-id-type="pmid">39078026</pub-id>
</element-citation></ref><ref id="B102-vaccines-12-01411"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nusbaum</surname><given-names>N.J.</given-names></name>
</person-group><article-title>The COVID Vaccination Hesitancy Epidemic</article-title><source>J. Community Health</source><year>2024</year><volume>49</volume><fpage>377</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1007/s10900-024-01350-9</pub-id><pub-id pub-id-type="pmid">38485803</pub-id>
</element-citation></ref><ref id="B103-vaccines-12-01411"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Diekema</surname><given-names>D.S.</given-names></name>
</person-group><article-title>Responding to parental refusals of immunization of children</article-title><source>Pediatrics</source><year>2005</year><volume>115</volume><fpage>1428</fpage><lpage>1431</lpage><pub-id pub-id-type="doi">10.1542/peds.2005-0316</pub-id><pub-id pub-id-type="pmid">15867060</pub-id>
</element-citation></ref><ref id="B104-vaccines-12-01411"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alya</surname><given-names>W.A.</given-names></name>
<name><surname>Maraqa</surname><given-names>B.</given-names></name>
<name><surname>Nazzal</surname><given-names>Z.</given-names></name>
<name><surname>Odeh</surname><given-names>M.</given-names></name>
<name><surname>Makhalfa</surname><given-names>R.</given-names></name>
<name><surname>Nassif</surname><given-names>A.</given-names></name>
<name><surname>Aabed</surname><given-names>M.</given-names></name>
</person-group><article-title>COVID-19 vaccine uptake and its associated factors among Palestinian healthcare workers: Expectations beaten by reality</article-title><source>Vaccine</source><year>2022</year><volume>40</volume><fpage>3713</fpage><lpage>3719</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2022.05.026</pub-id><pub-id pub-id-type="pmid">35595663</pub-id>
</element-citation></ref><ref id="B105-vaccines-12-01411"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zintel</surname><given-names>S.</given-names></name>
<name><surname>Flock</surname><given-names>C.</given-names></name>
<name><surname>Arbogast</surname><given-names>A.L.</given-names></name>
<name><surname>Forster</surname><given-names>A.</given-names></name>
<name><surname>von Wagner</surname><given-names>C.</given-names></name>
<name><surname>Sieverding</surname><given-names>M.</given-names></name>
</person-group><article-title>Gender differences in the intention to get vaccinated against COVID-19: A systematic review and meta-analysis</article-title><source>J. Public Health</source><year>2023</year><volume>31</volume><fpage>1303</fpage><lpage>1327</lpage><pub-id pub-id-type="doi">10.1007/s10389-021-01677-w</pub-id></element-citation></ref><ref id="B106-vaccines-12-01411"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nachtigall</surname><given-names>I.</given-names></name>
<name><surname>Bonsignore</surname><given-names>M.</given-names></name>
<name><surname>Hohenstein</surname><given-names>S.</given-names></name>
<name><surname>Bollmann</surname><given-names>A.</given-names></name>
<name><surname>G&#x000fc;nther</surname><given-names>R.</given-names></name>
<name><surname>Kodde</surname><given-names>C.</given-names></name>
<name><surname>Englisch</surname><given-names>M.</given-names></name>
<name><surname>Ahmad-Nejad</surname><given-names>P.</given-names></name>
<name><surname>Schr&#x000f6;der</surname><given-names>A.</given-names></name>
<name><surname>Glenz</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>Effect of gender, age and vaccine on reactogenicity and incapacity to work after COVID-19 vaccination: A survey among health care workers</article-title><source>BMC Infect. Dis.</source><year>2022</year><volume>22</volume><elocation-id>291</elocation-id><pub-id pub-id-type="doi">10.1186/s12879-022-07284-8</pub-id><pub-id pub-id-type="pmid">35346089</pub-id>
</element-citation></ref><ref id="B107-vaccines-12-01411"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Di Resta</surname><given-names>C.</given-names></name>
<name><surname>Ferrari</surname><given-names>D.</given-names></name>
<name><surname>Vigan&#x000f2;</surname><given-names>M.</given-names></name>
<name><surname>Moro</surname><given-names>M.</given-names></name>
<name><surname>Sabetta</surname><given-names>E.</given-names></name>
<name><surname>Minerva</surname><given-names>M.</given-names></name>
<name><surname>Ambrosio</surname><given-names>A.</given-names></name>
<name><surname>Locatelli</surname><given-names>M.</given-names></name>
<name><surname>Tomaiuolo</surname><given-names>R.</given-names></name>
</person-group><article-title>The Gender Impact Assessment among Healthcare Workers in the SARS-CoV-2 Vaccination&#x02014;An Analysis of Serological Response and Side Effects</article-title><source>Vaccines</source><year>2021</year><volume>9</volume><elocation-id>522</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines9050522</pub-id><pub-id pub-id-type="pmid">34070196</pub-id>
</element-citation></ref><ref id="B108-vaccines-12-01411"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sallam</surname><given-names>M.</given-names></name>
<name><surname>Dababseh</surname><given-names>D.</given-names></name>
<name><surname>Eid</surname><given-names>H.</given-names></name>
<name><surname>Al-Mahzoum</surname><given-names>K.</given-names></name>
<name><surname>Al-Haidar</surname><given-names>A.</given-names></name>
<name><surname>Taim</surname><given-names>D.</given-names></name>
<name><surname>Yaseen</surname><given-names>A.</given-names></name>
<name><surname>Ababneh</surname><given-names>N.A.</given-names></name>
<name><surname>Bakri</surname><given-names>F.G.</given-names></name>
<name><surname>Mahafzah</surname><given-names>A.</given-names></name>
</person-group><article-title>High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: A study in Jordan and Kuwait among other Arab countries</article-title><source>Vaccines</source><year>2021</year><volume>9</volume><elocation-id>42</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines9010042</pub-id><pub-id pub-id-type="pmid">33445581</pub-id>
</element-citation></ref><ref id="B109-vaccines-12-01411"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>She</surname><given-names>J.</given-names></name>
<name><surname>Hou</surname><given-names>D.</given-names></name>
<name><surname>Chen</surname><given-names>C.</given-names></name>
<name><surname>Bi</surname><given-names>J.</given-names></name>
<name><surname>Song</surname><given-names>Y.</given-names></name>
</person-group><article-title>Challenges of vaccination and herd immunity in COVID-19 and management strategies</article-title><source>Clin. Respir. J.</source><year>2022</year><volume>16</volume><fpage>708</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1111/crj.13543</pub-id><pub-id pub-id-type="pmid">36172975</pub-id>
</element-citation></ref><ref id="B110-vaccines-12-01411"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dassarma</surname><given-names>B.</given-names></name>
<name><surname>Tripathy</surname><given-names>S.</given-names></name>
<name><surname>Chabalala</surname><given-names>M.</given-names></name>
<name><surname>Matsabisa</surname><given-names>M.G.</given-names></name>
</person-group><article-title>Challenges in Establishing Vaccine Induced Herd Immunity through Age Specific Community Vaccinations</article-title><source>Aging Dis.</source><year>2022</year><volume>13</volume><fpage>29</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.14336/AD.2021.0611</pub-id><pub-id pub-id-type="pmid">35111360</pub-id>
</element-citation></ref><ref id="B111-vaccines-12-01411"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Goldberg</surname><given-names>A.R.</given-names></name>
<name><surname>Langwig</surname><given-names>K.E.</given-names></name>
<name><surname>Brown</surname><given-names>K.L.</given-names></name>
<name><surname>Marano</surname><given-names>J.M.</given-names></name>
<name><surname>Rai</surname><given-names>P.</given-names></name>
<name><surname>King</surname><given-names>K.M.</given-names></name>
<name><surname>Sharp</surname><given-names>A.K.</given-names></name>
<name><surname>Ceci</surname><given-names>A.</given-names></name>
<name><surname>Kailing</surname><given-names>C.D.</given-names></name>
<name><surname>Kailing</surname><given-names>M.J.</given-names></name>
<etal/>
</person-group><article-title>Widespread exposure to SARS-CoV-2 in wildlife communities</article-title><source>Nat. Commun.</source><year>2024</year><volume>15</volume><fpage>6210</fpage><pub-id pub-id-type="doi">10.1038/s41467-024-49891-w</pub-id><pub-id pub-id-type="pmid">39075057</pub-id>
</element-citation></ref><ref id="B112-vaccines-12-01411"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Delahay</surname><given-names>R.J.</given-names></name>
<name><surname>de la Fuente</surname><given-names>J.</given-names></name>
<name><surname>Smith</surname><given-names>G.C.</given-names></name>
<name><surname>Sharun</surname><given-names>K.</given-names></name>
<name><surname>Snary</surname><given-names>E.L.</given-names></name>
<name><surname>Flores Gir&#x000f3;n</surname><given-names>L.</given-names></name>
<name><surname>Nziza</surname><given-names>J.</given-names></name>
<name><surname>Fooks</surname><given-names>A.R.</given-names></name>
<name><surname>Brookes</surname><given-names>S.M.</given-names></name>
<name><surname>Lean</surname><given-names>F.Z.X.</given-names></name>
<etal/>
</person-group><article-title>Assessing the risks of SARS-CoV-2 in wildlife</article-title><source>One Health Outlook</source><year>2021</year><volume>3</volume><fpage>7</fpage><pub-id pub-id-type="doi">10.1186/s42522-021-00039-6</pub-id><pub-id pub-id-type="pmid">33834160</pub-id>
</element-citation></ref><ref id="B113-vaccines-12-01411"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Valencak</surname><given-names>T.G.</given-names></name>
<name><surname>Csiszar</surname><given-names>A.</given-names></name>
<name><surname>Szalai</surname><given-names>G.</given-names></name>
<name><surname>Podlutsky</surname><given-names>A.</given-names></name>
<name><surname>Tarantini</surname><given-names>S.</given-names></name>
<name><surname>Fazekas-Pongor</surname><given-names>V.</given-names></name>
<name><surname>Papp</surname><given-names>M.</given-names></name>
<name><surname>Ungvari</surname><given-names>Z.</given-names></name>
</person-group><article-title>Animal reservoirs of SARS-CoV-2: Calculable COVID-19 risk for older adults from animal to human transmission</article-title><source>Geroscience</source><year>2021</year><volume>43</volume><fpage>2305</fpage><lpage>2320</lpage><pub-id pub-id-type="doi">10.1007/s11357-021-00444-9</pub-id><pub-id pub-id-type="pmid">34460063</pub-id>
</element-citation></ref><ref id="B114-vaccines-12-01411"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shaheen</surname><given-names>M.N.F.</given-names></name>
</person-group><article-title>The concept of one health applied to the problem of zoonotic diseases</article-title><source>Rev. Med. Virol.</source><year>2022</year><volume>32</volume><fpage>e2326</fpage><pub-id pub-id-type="doi">10.1002/rmv.2326</pub-id><pub-id pub-id-type="pmid">35060214</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="vaccines-12-01411-f001"><label>Figure 1</label><caption><p>PRISMA 2020 flow diagram for new systematic reviews which included searches of databases and registers only for this scoping review.</p></caption><graphic xlink:href="vaccines-12-01411-g001" position="float"/></fig><table-wrap position="float" id="vaccines-12-01411-t001"><object-id pub-id-type="pii">vaccines-12-01411-t001_Table 1</object-id><label>Table 1</label><caption><p>Characteristics of included studies (publication year, study type, country of origin, number of participants, vaccine history and hesitancy rates).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Author/Year (Ref.)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study Type</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Country</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">No of Participants</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Vaccination History (%) Number of BDs Received</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Vaccine Hesitancy (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Hesitancy Among HCPs by Specialty</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arshad et al., 2022 [<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pakistan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 1164</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.9% at least one BD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.9%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.4% Medical professionals<break/>23.7% Allied Health Professionals</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dale et al., 2023 [<xref rid="B41-vaccines-12-01411" ref-type="bibr">41</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">England</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 91</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">77.1% at least one BD<break/>4.9% 2 BDs<break/>1.2% 3 BDs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oxford Vaccine hesitancy scale score: 13.56/35.00 (17.1% being above the midpoint).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Della Polla et al., 2022 [<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Italy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 496</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">94.9% at least one BD<break/>48.1% at least 2 BDs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.4%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Digregorio et al., 2024 [<xref rid="B57-vaccines-12-01411" ref-type="bibr">57</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Belgium</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 1814</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">66.8% 2 BDs<break/>6.3% 3 BDs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dudley et al., 2023 [<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">USA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 1207</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82% HCPs at least one BD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.3% Pediatrician<break/>13% Family medicine<break/>26.7% Physician assistant, Nurse Practitioners, and Nurse<break/>26% Pharmacist</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Galanis et al., 2023 [<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Greece</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 795</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30.9%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">George et al., 2023 [<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mixed-Methods</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">South Africa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 6235</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56% at least one BD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.9% Nurse<break/>17.5% Doctor</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gu et al., 2023 [<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">China</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 1618</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">78.4% at least one BD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41.8%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43.7% Physician<break/>37% Nurse</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Guarducci et al., 2023 [<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Italy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 1309</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96.5% one BD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kolomba et al., 2024 [<xref rid="B58-vaccines-12-01411" ref-type="bibr">58</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Congo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 514</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.3% one BD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.1%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.1% Doctor</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Krishna et al., 2023 [<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 535</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.2% one BD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lubad et al., 2023 [<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jordan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 300</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31.6%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Maraga et al., 2024 [<xref rid="B22-vaccines-12-01411" ref-type="bibr">22</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Palestine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 919</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">66.5%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pandarathodiyil et al., 2024 [<xref rid="B59-vaccines-12-01411" ref-type="bibr">59</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Malaysa</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 392</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100% at least one BD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Paudel et al., 2023 [<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nepal</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 300</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29% one BD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pristov al., 2024 [<xref rid="B60-vaccines-12-01411" ref-type="bibr">60</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Slovenia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 560</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50.9% at least one BD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ramot et al., 2023 [<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Israel</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 124</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">88.7% one BD<break/>38.7% 2 BDs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">61.3%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rathinakumar et al., 2024 [<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">South India</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 572</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.6% one BD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.7%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.2% Paramedical workers<break/>12.8% Doctor</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Roberts et al. 2024 [<xref rid="B61-vaccines-12-01411" ref-type="bibr">61</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">USA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 182</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55% one BD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Russ et al., 2024 [<xref rid="B62-vaccines-12-01411" ref-type="bibr">62</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">USA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 3375</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">85% one BD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Salah et al., 2023 [<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kingdom of Bahrain and Egypt</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 389</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.1%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.1% Physicians<break/>26% Nurses<break/>34.6% Pharmacists</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sansone et al., 2024 [<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Italy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 521</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.2% at least one BD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60.2%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Viskupi&#x0010d; et al., 2023 [<xref rid="B55-vaccines-12-01411" ref-type="bibr">55</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">USA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 1084</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">63.2% one BD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zoumpoulis et al., 2023 [<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quantitative</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Greece</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">n</italic> = 1224</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52.4% one BD<break/>47.5% 2 BDs</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.4%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NR</td></tr></tbody></table><table-wrap-foot><fn><p>BD: booster dose, HCP: healthcare professional, NR: not reported.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="vaccines-12-01411-t002"><object-id pub-id-type="pii">vaccines-12-01411-t002_Table 2</object-id><label>Table 2</label><caption><p>Socio-demographic characteristics and COVID-19-related variables associated with vaccination hesitancy.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Factors</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Associated with Hesitancy</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Studies</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">
<bold>Age</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">Younger age [<xref rid="B39-vaccines-12-01411" ref-type="bibr">39</xref>,<xref rid="B41-vaccines-12-01411" ref-type="bibr">41</xref>,<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>,<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Gender</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Being male [<xref rid="B34-vaccines-12-01411" ref-type="bibr">34</xref>,<xref rid="B39-vaccines-12-01411" ref-type="bibr">39</xref>].<break/>Being female [<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">
<bold>Race</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">Black African [<xref rid="B39-vaccines-12-01411" ref-type="bibr">39</xref>].<break/>Black [<xref rid="B55-vaccines-12-01411" ref-type="bibr">55</xref>].<break/>Non-Hispanic Black [<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>].<break/>Hispanic [<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Education</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lower education [<xref rid="B38-vaccines-12-01411" ref-type="bibr">38</xref>,<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">
<bold>Occupation</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">Non-prescribers [<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>].<break/>Other than physicians [<xref rid="B37-vaccines-12-01411" ref-type="bibr">37</xref>,<xref rid="B38-vaccines-12-01411" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01411" ref-type="bibr">39</xref>,<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>].<break/>Physicians [<xref rid="B41-vaccines-12-01411" ref-type="bibr">41</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>].<break/>Pharmacists [<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>].<break/>&#x0039d;ot in direct contact with patients [<xref rid="B39-vaccines-12-01411" ref-type="bibr">39</xref>].<break/>Less job experience [<xref rid="B39-vaccines-12-01411" ref-type="bibr">39</xref>].<break/>Working experience more than 5&#x02009;years [<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>].<break/>Wards of activity with lower risk of infection (Medical vs. Emergency/Critical/Infectious Disease wards) [<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">12</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Political Leanings</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Republican self-identification [<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">
<bold>Marital Status</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">Single/not married [<xref rid="B34-vaccines-12-01411" ref-type="bibr">34</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>].<break/>Married [<xref rid="B38-vaccines-12-01411" ref-type="bibr">38</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Friends/family</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Influence of friends/family [<xref rid="B35-vaccines-12-01411" ref-type="bibr">35</xref>,<xref rid="B38-vaccines-12-01411" ref-type="bibr">38</xref>,<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">
<bold>Area of Residence</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">Rural [<xref rid="B34-vaccines-12-01411" ref-type="bibr">34</xref>,<xref rid="B37-vaccines-12-01411" ref-type="bibr">37</xref>].<break/>Highly socially vulnerable census tract [<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Low income</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low annual household income (&#x0003c;USD 50,000) [<xref rid="B56-vaccines-12-01411" ref-type="bibr">56</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">
<bold>Comorbidity/chronic illness</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">Absence of chronic conditions [<xref rid="B38-vaccines-12-01411" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01411" ref-type="bibr">39</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>].<break/>Permanent or temporary medical conditions [<xref rid="B37-vaccines-12-01411" ref-type="bibr">37</xref>].<break/>History of allergy [<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>].<break/>Obesity [<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Health status</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Good/very good self-perceived physical health [<xref rid="B38-vaccines-12-01411" ref-type="bibr">38</xref>].<break/>Unhealthy dietary habits [<xref rid="B54-vaccines-12-01411" ref-type="bibr">54</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">
<bold>Time constraints</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">Lack of time [<xref rid="B35-vaccines-12-01411" ref-type="bibr">35</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Flu Vaccination</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lack of flu vaccination [<xref rid="B17-vaccines-12-01411" ref-type="bibr">17</xref>,<xref rid="B38-vaccines-12-01411" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01411" ref-type="bibr">39</xref>,<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">
<bold>Hygiene measures</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">Increased compliance [<xref rid="B38-vaccines-12-01411" ref-type="bibr">38</xref>,<xref rid="B41-vaccines-12-01411" ref-type="bibr">41</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Relating to COVID-19</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Previous COVID-19 infection [<xref rid="B34-vaccines-12-01411" ref-type="bibr">34</xref>,<xref rid="B35-vaccines-12-01411" ref-type="bibr">35</xref>,<xref rid="B49-vaccines-12-01411" ref-type="bibr">49</xref>].<break/>No previous infection [<xref rid="B38-vaccines-12-01411" ref-type="bibr">38</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">
<bold>Relating to COVID-19 vaccination</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">No previous vaccination [<xref rid="B34-vaccines-12-01411" ref-type="bibr">34</xref>]<break/>Type of vaccine (non-mRNA COVID-19 vaccines) [<xref rid="B34-vaccines-12-01411" ref-type="bibr">34</xref>,<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>] <break/>Less previous vaccine doses [<xref rid="B44-vaccines-12-01411" ref-type="bibr">44</xref>,<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>]<break/>Uptake of the first booster dose [<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>]<break/>Previous side effects [<xref rid="B34-vaccines-12-01411" ref-type="bibr">34</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">10</td></tr></tbody></table></table-wrap><table-wrap position="float" id="vaccines-12-01411-t003"><object-id pub-id-type="pii">vaccines-12-01411-t003_Table 3</object-id><label>Table 3</label><caption><p>Knowledge/attitudes associated with vaccine hesitancy.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Knowledge/Attitudes</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Associated with Hesitancy</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Studies</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">
<bold>Trust-related issues</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">Vaccine safety [<xref rid="B34-vaccines-12-01411" ref-type="bibr">34</xref>,<xref rid="B35-vaccines-12-01411" ref-type="bibr">35</xref>,<xref rid="B38-vaccines-12-01411" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01411" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B41-vaccines-12-01411" ref-type="bibr">41</xref>,<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">11</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pregnancy safety [<xref rid="B35-vaccines-12-01411" ref-type="bibr">35</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">Vaccine effectiveness [<xref rid="B17-vaccines-12-01411" ref-type="bibr">17</xref>,<xref rid="B34-vaccines-12-01411" ref-type="bibr">34</xref>,<xref rid="B36-vaccines-12-01411" ref-type="bibr">36</xref>,<xref rid="B38-vaccines-12-01411" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01411" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B41-vaccines-12-01411" ref-type="bibr">41</xref>,<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B53-vaccines-12-01411" ref-type="bibr">53</xref>,<xref rid="B55-vaccines-12-01411" ref-type="bibr">55</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">16</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaccine necessity [<xref rid="B35-vaccines-12-01411" ref-type="bibr">35</xref>,<xref rid="B36-vaccines-12-01411" ref-type="bibr">36</xref>,<xref rid="B38-vaccines-12-01411" ref-type="bibr">38</xref>,<xref rid="B39-vaccines-12-01411" ref-type="bibr">39</xref>,<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B55-vaccines-12-01411" ref-type="bibr">55</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">Vaccine Side effects [<xref rid="B17-vaccines-12-01411" ref-type="bibr">17</xref>,<xref rid="B36-vaccines-12-01411" ref-type="bibr">36</xref>,<xref rid="B37-vaccines-12-01411" ref-type="bibr">37</xref>,<xref rid="B46-vaccines-12-01411" ref-type="bibr">46</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>,<xref rid="B55-vaccines-12-01411" ref-type="bibr">55</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mistrust in government/scientists [<xref rid="B37-vaccines-12-01411" ref-type="bibr">37</xref>,<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">Rapid development of the vaccines [<xref rid="B37-vaccines-12-01411" ref-type="bibr">37</xref>,<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Distrust due to racism and previous unethical treatment of minorities [<xref rid="B37-vaccines-12-01411" ref-type="bibr">37</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">Reliability of clinical trials (not including HCPs) [<xref rid="B37-vaccines-12-01411" ref-type="bibr">37</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low trust and satisfaction in COVID-19 vaccination [<xref rid="B34-vaccines-12-01411" ref-type="bibr">34</xref>,<xref rid="B38-vaccines-12-01411" ref-type="bibr">38</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">Wanting to wait more [<xref rid="B37-vaccines-12-01411" ref-type="bibr">37</xref>,<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B45-vaccines-12-01411" ref-type="bibr">45</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Information</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lack of information/misinformation [<xref rid="B42-vaccines-12-01411" ref-type="bibr">42</xref>,<xref rid="B47-vaccines-12-01411" ref-type="bibr">47</xref>,<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">
<bold>Beliefs and attitudes about health and prevention</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">Low risk of COVID-19 infection [<xref rid="B36-vaccines-12-01411" ref-type="bibr">36</xref>,<xref rid="B37-vaccines-12-01411" ref-type="bibr">37</xref>,<xref rid="B40-vaccines-12-01411" ref-type="bibr">40</xref>,<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immune system capable of fighting COVID-19 [<xref rid="B43-vaccines-12-01411" ref-type="bibr">43</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">Lower perception of the severity of COVID-19 [<xref rid="B36-vaccines-12-01411" ref-type="bibr">36</xref>,<xref rid="B41-vaccines-12-01411" ref-type="bibr">41</xref>,<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Against vaccines in general [<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>,<xref rid="B52-vaccines-12-01411" ref-type="bibr">52</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">Belief in greater efficacy of complementary alternative medicine [<xref rid="B50-vaccines-12-01411" ref-type="bibr">50</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Ethics</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mandatory Vaccination [<xref rid="B39-vaccines-12-01411" ref-type="bibr">39</xref>,<xref rid="B41-vaccines-12-01411" ref-type="bibr">41</xref>,<xref rid="B48-vaccines-12-01411" ref-type="bibr">48</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">
<bold>Other</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">Not being very likely to suggest the vaccine to patients [<xref rid="B51-vaccines-12-01411" ref-type="bibr">51</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#CCCCCC" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tiredness due to the vaccination procedure [<xref rid="B38-vaccines-12-01411" ref-type="bibr">38</xref>].</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr></tbody></table></table-wrap></floats-group></article>